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1 INTRODUCTION 
 
1.1 Proteases   
Enzymes are present in every living organism and catalyze countless of different 
chemical reactions. In biotechnology and biochemistry, the impressive repertoire of 
biocatalysts is utilized for chemical synthesis. Enzymes are often energy-efficient and 
environmentally friendly catalysts, as they are highly active under mild conditions and 
generate only few waste products (Arnold 2001). 
Proteases catalyze the hydrolysis of peptide and ester bonds. Based upon the nature 
of the nucleophile in the hydrolysis reaction, they are broadly grouped into six 
catalytic types: serine, threonine, cystein, aspartic, glutamic and metallo-proteases 
(Rawlings et al. 2011). Approximately 40 % of the total enzyme sales account for 
proteases. Serine proteases are the most exploited industrially group within the 
protease family. Besides their important role in cellular metabolic processes these 
enzymes have become widely used in detergent industry since the introduction of 
pancreatic extracts in 1913 as detergent additive. Additionally, serine proteases are 
used in various industrial sectors such as food, pharmaceutical, leather, diagnostics 
and waste management (Gupta et al. 2002; Maurer 2004). 
 
1.2 Proteases in detergent applications 
Detergent formulations commonly contain enzymes like proteases to remove 
proteinaceous stains from textiles during the washing process. Additionally lipases, 
amylases and cellulases are supplemented to boost the washing performance. 
Nowadays detergent proteases from microbial sources are screened for hydrolytic 
activity on protein substrates and the potential candidates are isolated and tested 
under application conditions (Von der Osten et al. 1993). However, nature has 
evolved enzymes for millions of years towards the catalysis of specific reactions in 
distinct natural reaction environments. The identification and utilization of enzymes 
fulfilling all industrial requirements is therefore like looking for a needle in a haystack.  
In detergent applications, the major challenges for an efficient implementation of 
proteases are producibility, stability, low substrate specificity, activity at low or high 
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pH, ionic strength behavior and resistance towards thermal treatment, surfactants 
and detergents (Farinas et al. 2001; Nascimento and Martins 2006). Subtilisins, an 
extracellular produced group of serine proteases, fulfill to a certain extent several 
requirements like resistance towards high temperature and surfactants as well as low 
substrate specificity and activity at alkaline pH. 
With the change in consumer’s preference towards liquid detergent formulations the 
working environment of detergent proteases has changed dramatically, therefore 
new proteases or the adaptation of detergent proteases to the new environment is a 
prerequisite for the effective removal of proteinaceous stains during the washing 
process. Among other characteristics the pH value of the distinct formulation plays an 
important role for the washing performance of the embedded proteases. The pH-
value of powder formulations (pH ~10) is two units higher compared to liquid 
detergent formulations (pH ~8). The pH dependent activity of subtilisins or enzymes 
in general is not completely understood; therefore a rational strategy to shift the pH 
optimum of detergent proteases towards increased activity at pH values below pH 
10, would enable the fast and effective adaptation of proteases used in powder 
formulations for their application in liquid detergents. 
In powder and liquid detergent formulations the primary cause of inactivation differs. 
Proteases in powder formulation are granulated and therefore show low water activity 
or autoproteolytic degradation. The main cause for inactivation is oxidative 
inactivation during storage by bleaching agents like perborates and percarbonates. 
On the other hand, as liquid formulations don’t include bleaching agents, the main 
cause of inactivation for proteases is autoproteolytic degradation. Additionally, 
proteolytic active proteases in liquid detergents lead to the degradation of other 
embedded enzymatic components like cellulases, amylases or lipases (Von der 
Osten et al. 1993). 
Nowadays the inhibition of proteases in liquid detergent formulation is commonly 
accomplished by the supplementation of boric acid (Severson 1985). The 
stabilization and specifically the inhibition of proteases during storage became an 
intense challenge for the detergent industry, because the application of boric acid is 
due to its toxic potential controversially discussed and therefore the identification and 
application of alternative boron free inhibitors is of high interest. 
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Besides the new requirements for detergent proteases, which were caused by the 
introduction of liquid detergents to the market, the cost effective production of 
proteases for laundry detergents is an ongoing challenge and alternative 
straightforward and universal strategies to increase the protease production are of 
high importance for detergent industry. 
 
1.3 Serine Proteases 
The common reaction mechanism of serine proteases is shown in Figure 1. The 
catalytic triad consists of serine, histidine and aspartic acid. Once the substrate is 
bound, a nucleophilic attack of the serine oxygen to the peptide carbonyl group 
initiates the acylation reaction. The formed instable tetrahedral intermediate is 
stabilized by amide hydrogens coordinating the anionic oxygen. This protein area is 
known as the oxyanion hole. The tetrahedral intermediate decomposes to an acyl-
enzyme by breaking the peptide bond and the amino group leaves the substrate-
enzyme complex. The deacylation of the enzyme is initiated by a nucleophilic attack 
of a water molecule present at the catalytically active histidine. The histidine 
protonates while the resulting hydroxyl group forms a covalent bond to the carbonyl 
carbon. The resulting tetrahedral intermediate is again stabilized by the oxyanion 
hole. In the last step the tetrahedral intermediate decomposes by breaking the bond 
to serine hydroxyl group and the carboxylic acid product leaves the active site. The 
enzyme is again ready for the next reaction (Polgar 2005; Walker and Lynas 2001). 
 
Figure 1: The hydrolysis reaction of serine proteases. a) The acylation reaction is the rate limiting 
step, defining the kcat. b) The deacylation step is reported to be >33 faster than the acylation (Branden 
and Tooze 1999; Wells and Estell 1988). 
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1.4 Protein engineering of subtilisins  
Enzymes are sophisticated catalysts which might consist of multiple subunit 
complexes and depend on cofactors or metal ions to carry out reactions. The single 
domain α/β-fold serine proteases, mainly secreted by Bacillus sp., are easily assayed 
and can be efficiently produced in gram-per-liter amounts by protease deficient 
strains such as B. amyloliquefaciens or B. licheniformis, achieving up to ~30 % of the 
total secreted protein (Wells and Estell 1988). By their catalytic mechanism subtilisins 
are defined as serine proteases (Figure 1). Based on the amino acid sequence and 
three-dimensional structure subtilisins can be clearly differentiated from other serine 
proteases, such as chymotrypsin, carboxypeptidase and peptidase A from E. coli 
(Branden and Tooze 1999; Maurer 2004). Enormous structural evidence of subtilisins 
is provided; in 2012 more than 250 entries for subtilisin structures are available in the 
protein data bank (http://www.rcsb.org; Figure 2). Success factors for subtilisins for 
the application in detergent industry are high stability and relatively low substrate 
specificity. Both features are common for extracellular produced proteases. 
In the last decade, extensive protein engineering approaches -mainly accomplished 
by directed evolution- focused on altering the substrate specificity (Rheinnecker et al. 
1993), general stability (Takagi et al. 2000) and proteolytic activity (Sternberg et al. 
1987) of subtilisins. Amino acid substitutions in over 50 % of the 275 amino acids 
were performed and reported (Bryan 2000; Leisola and Turunen 2007). In the last 
years, the focus of protease engineering shifted towards engineering subtilisins and 
other proteases towards novel and precise amino acid sequence-specific cleavage 
for the use in analytical, biotechnological and therapeutic applications, since a single 
protease molecule can inactivate, due to its catalytic turnover, numerous target 
proteins (Craik et al. 2011; Pogson et al. 2009). For example, subtilisin BPN’ was 
through iterative modeling, mutagenesis and kinetic analysis cycles, tailored to 
preferentially cleave phosphotyrosine peptides (2500-fold enhanced relative to the 
wild type; Knight et al. 2007). Amino acid substitutions responsible for the modified 
substrate specificity are mainly located in or around the S1 specificity pockets and 
the active site (Di Cera 2008; Figure 2). Recently, the protease subtilisin E was 
engineered for the application in DNA-sequence-based diagnostic kits requiring high 
activity and resistance towards chaotrophic salts and detergents (Li et al. 2012) and 
another subtilisin protease from Bacillus gibsonii was adapted for high thermo 
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stability and increased activity at low temperatures (15°C) for the use in liquid 
detergent formulations (Martinez et al. 2012). 
 
Figure 2: Crystal structure of Bacillus lentus alkaline protease (Goddette et al. 1992). Red: β-sheets. 
Blue: α-helices. Cyan: catalytic triad consisting of aspartate 32, histidine 62 and serine 215. Magenta: 
asparagine 153 (oxyanion hole). Yellow: calcium ions. Green: S1 pocket. 
 
1.5  Protein engineering: directed evolution and rational design 
Directed protein evolution represents the most versatile method for tailoring enzyme 
properties for industrial application requirements and for generating valuable 
information to understand structure-function relationships (Wong et al. 2006). Starting 
a directed evolution experiment does not require an understanding of structure-
function relationships of the target protein and can be also applied to newly 
discovered enzymes for which no crystal structure has been solved and/or key amino 
   INTRODUCTION 
6 
 
acid positions are unknown. The three major steps of directed evolution experiments 
are shown in Figure 3. The generation of a diverse mutant library includes the 
introduction of random mutations in the gene of interest and transformation of the 
mutated gene in an appropriate expression host (Step I). The generated mutant 
library is screened for improved variants using a suitable screening system (Step II). 
Genes encoding for improved variants are isolated and are usually used for iterative 
rounds of diversity generation and screening until a target improvement of the 
desired enzyme property is achieved (Wong et al. 2006).  
 
Figure 3: General overview of a directed evolution experiment. Scheme according to Güven et al. 
2010. 
The two main challenges in directed evolution campaigns are an unbiased diversity 
generation and development of specialized screening systems which enable the 
sampling of a meaningful mutant fraction in a reliable and timely way (Wong et al. 
2006). 
The most commonly used random mutagenesis techniques are enzyme based 
methods, introducing random mutations in the gene of interest under low fidelity 
conditions. The workhorse in directed protein evolution is Taq DNA polymerase from 
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Thermus aquaticus lacking 3’-5’ proofreading exonuclease activity; however, its 
error-rate (1 mutation per 125.000 bp per PCR cycle) is not sufficient to generate 
mutant libraries. The most prominent methods to increase the error rates in a PCR 
reaction are the addition of MnCl2, supplementing unbalanced nucleotide 
concentrations and increasing the number of amplification cycles (Cirino et al. 2003). 
Though versatile and simple, error-prone PCR (epPCR) methods are still significantly 
limited in their ability to create diversity on the gene level. An epPCR carried out 
under standard conditions can in average generate less than 40 % of all possible 
amino acid substitutions due to the biased mutational spectra of DNA polymerases, 
the lack of subsequent mutations due to low mutation frequencies and the redundant 
genetic code (Shivange et al. 2009). One of the latest developed random 
mutagenesis methods is the Sequence Saturation Mutagenesis (SeSaM), which 
overcomes limitations caused by biased DNA polymerases (Wong et al. 2005). 
SeSaM consists of four steps and is capable of saturating every single nucleotide 
position in the target sequence with all four standard nucleotides. A pool of DNA 
fragments with random length distribution is generated in a first PCR using α-
phosphothioated nucleotides (Step 1). The generated DNA fragments are tailed at 
the 3’-termini with universal bases using terminal transferase (Step 2). The elongated 
DNA fragments are extended to full-length genes (Step 3). A concluding PCR is 
performed to replace the universal bases with standard nucleotides (Step 4; Figure 
4). 
 
Figure 4: General scheme of SeSaM random mutagenesis: 1) Fragment generation, 2) Addition of 
universal base(s), 3) Fragment library elongation, and 4) Universal base replacements. The main 
improvements in steps 1, 2 and 3 are summarized in the corresponding columns (Mundhada et al. 
2011). 
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The method of choice for mutant library generation depends highly on the enzyme 
property which is aimed to be engineered. Engineering a property like thermal 
stability usually requires high mutational load with amino acid substitutions towards 
chemically different amino acids, leading to SeSaM as a method of choice. The error-
prone based methods lead to similar amino acid substitutions, which could be 
beneficial, for example, for modifying the enantioselectivity of an enzyme (Arnold 
2001; Reetz and Jaeger 1999).  
Another challenge in a directed evolution campaign is the availability of an 
appropriate screening system for the desired property. The screening procedure is a 
time consuming experimental work, and is the critical point that often determines if a 
directed evolution campaign succeeds or fails. The screening conditions have to 
reflect as close as possible the final application conditions, including substrate, 
temperature and environmental stress. The screening system has to be specially 
developed for each enzyme, should be compatible for medium and/or high 
throughput screening and sensitive over the final application range of the substrate 
concentration, enabling the identification of desired hits in the generated library 
(Aharoni et al. 2005). The most commonly used formats are microtiter plate 
screening systems (96-, 384- or 1536-wells) based on colorimetric or fluorimetric 
reactions. The microtiter plate systems are nowadays considered as medium 
throughput (103 to 105; Cohen et al. 2001). Solid phase screening systems, 
commonly based on agar plates, filter papers or membranes, are considered as high 
throughput (104 to 106; Shivange et al. 2012). Solid phase screening systems 
commonly lack in resolution, but allow qualitative differentiation between active and 
inactive variants. They are widely used as pre-screening systems, due to their high 
throughput, followed by microtiter plate based screening procedures (Li et al. 2012). 
The introduction of flow cytometry-based screening systems to the field of directed 
evolution enabled ultra-high throughput screening of mutant libraries with more than 
107 clones per hour (Farinas 2006). This system is based on the detection of 
fluorescent signals generated by enzymatic reactions. Flow cytometry screening 
systems further enable the analysis of in vitro generated enzyme libraries 
(Mastrobattista et al. 2005) and greatly accelerate the screening process in directed 
evolution campaigns, but are only available for a few enzyme classes, yet.  Often 
only a qualitative differentiation between active and inactive enzyme variants from 
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high mutational load libraries is possible. The resulting enriched library is 
subsequently analyzed in depth. 
A commonly used approach to tailor enzyme properties is rational design. In contrast 
to a directed evolution campaign, a successful rational design strategy requires 
detailed knowledge about the targeted protein, including structural information and 
the molecular basis of the targeted property in order to propose amino acid 
substitutions affecting the desired protein property. The method of choice for the 
rational protein design is site-directed mutagenesis (Toscano et al. 2007). 
Semi-rational design bypasses limitations of directed protein evolution and rational 
design. Semi-rational design focuses on prior gained structural and functional 
knowledge targeting multiple relevant amino acid residues for site-saturation 
mutagenesis. The resulting ‘smart’ libraries are more likely to yield positive results. A 
comparison of different enzyme engineering approaches is given in Table 1 (Chica et 
al. 2005). 
Table 1: Comparison of different enzyme engineering approaches (Chica et al. 2005). 
 Rational design 
Directed evolution 
(Random mutagenesis) 
Semi-rational design 
High-throughput screening 
or selection method 
Not essential Essential Advantegeous but not essential 
Structural and/or functional 
information 
Both essential Neither essential Either sufficient 
Sequence space exploration Low Moderate, random 
Experimental: moderate, targeted               
Computational: vast, targeted 
Probability of obtaining 
synergistic mutations 
Moderate Low High 
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2 SURFACE CHARGE ENGINEERING OF BACILLUS GIBSONII ALKALINE 
PROTEASE 
2.1 Declaration 
Parts of this chapter were published by the author in the journal of Applied 
Microbiology and Biotechnology. 
 “Jakob F, Martinez R, Mandawe J, Hellmuth H, Siegert P, Maurer K-H, 
Schwaneberg U (2013) Surface charge engineering of a Bacillus gibsonii 
subtilisin protease. Appl Microbiol Biotechnol 97(15):6793-6802” 
 
2.2 Objective 
The objective was the development of a novel rational protein design strategy in 
order to alter the pH dependent activity and thermal resistance of the Bacillus gibsonii 
alkaline protease (BgAP) by surface charge engineering through rational single 
amino acid substitutions. The developed method was inspired by the natural post-
translational deamidation reaction, wherein Asn and Gln residues are converted to 
Asp and Glu, respectively. 
 
2.3 State of the art 
2.3.1 Influence of protein surfaces charges on enzyme properties 
The hydrophobic/hydrophilic balance and the charge distribution on the surface of 
proteins have significant effects on enzymatic performances like activity, thermal 
stability and pH optimum (Russell and Fersht 1987; Sakoda and Imanaka 1992; 
Sanchez-Ruiz and Makhatadze 2001; Grimsley et al. 1999). It was demonstrated that 
either the substitution of exposed hydrophobic amino acids against hydrophilic 
arginine or the addition of hydrophobic amino acids to the surface of a protein can 
increase protein stability (Strub et al. 2004; Van den Burg et al. 1998). 
Amino acid composition studies in proteins from thermophilic and mesophilic bacteria 
showed that charged amino acids like glutamic acid (Glu), aspartic acid (Asp), lysine 
(Lys) and arginine (Arg) are comparatively overrepresented at the surface of proteins 
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from thermophilic organisms, whereas buried residues show no significant difference 
in their composition (Fukuchi and Nishikawa 2001).  
The charge distribution and charge-charge interactions on protein surfaces have 
been widely studied, including ionic strength dependent activity, thermostability and 
pH-activity profile (De Kreij et al. 2002; Feller et al. 2010; Loladze et al. 1999). The 
pH-activity dependence on the protein surface charges has been reported for serine 
proteases from B. amyloliquefaciens, B. lentus, B. pumilus and B. stearothermophilus 
(De Kreij et al. 2002; DeSantis and Jones 1998; Jaouadi et al. 2010; Russell and 
Fersht 1987). Improvements in thermostability (up to 3-3.7-fold improved half-life 
times; Jaouadi et al. 2010) were achieved by single amino acid substitutions and by 
optimization of charge-charge interactions on the protein surface (Imanaka et al. 
1986; Jaouadi et al. 2010; Yutani et al. 1977). Recently, the relationship between 
specific enzyme activity and protein charge of chymotrypsin-like serine protease from 
Cellulomonas bogoriensis in solution with different ionic strengths was studied. 
Variants with increased positive charge showed a higher reaction rate at increased 
ionic strength, evidencing a clear influence of the protein charge on specific activity 
(Feller et al. 2010). 
2.3.2 The deamidation process and its influence on protein properties 
The amino acid residues asparagine (Asn) and glutamine (Gln) can be unstable 
under physiological conditions, undergoing a spontaneous non-enzymatic 
deamidation, resulting in aspartic acid (Asp) and glutamic acid (Glu). As a result, the 
number of amino acids with a negative charge in a protein increases. Beside aspartic 
and glutamic acid, a third product, iso-asparagine, can be generated with a ratio of 
3:1 (L-Asp to L-iso-Asp). The latter deamidation process has been described 
extensively and probable mechanisms were proposed (Capasso et al. 1989; Catak et 
al. 2009). Based on the deamidation process, a molecular clock hypothesis was 
proposed, in which the non-enzymatic deamidation (half-life time of asparagine and 
glutamine residues under physiological conditions) serves as a regulator or “timer” for 
biological processes (Robinson and Robinson 2004).  
As alternative to the non-enzymatic deamidation, enzymatic deamidation of proteins 
has been studied in the case of proteases with amidolytic activity, like papain, 
pronase and chymotrypsin at high alkaline pH (Kato et al. 1987b). Enzymatic 
deamidation proved to be a useful method for altering functional properties such as 
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emulsifying and foaming properties for food processing (Kato et al. 1987a; Kato et al. 
1987b).  
First protein engineering studies by exchanging Asn to Asp at two positions in hen 
egg-white lysozyme were performed in the 1990’s (Kato et al. 1992). The exchange 
of Asn to Asp shifted the pH optimum from a neutral to a more acidic pH-value 
(0.5 units shift). Thermostability of the deamidated variants was similar to the wild-
type lysozyme and protease digestion studies suggested an increased accessibility 
and therefore a higher flexibility within the Asp enriched lysozyme variants 
(Kato et al. 1992). 
Non-enzymatic deamidation of proteases by exposure to high ionic strength at 
neutral pH was for the first time reported in 1988, during crystallization of bovine 
trypsin (Kossiakoff 1988). Bovine trypsin was exposed to high ionic strength at 
neutral pH for more than one year. During the latter treatment, 3 out of 13 asparagine 
residues were deamidated, resulting in aspartic acid (Kossiakoff 1988). However, no 
systematic study has, to our best knowledge, been reported on property alterations 
(thermostability, pH-profile dependence, specific activity) caused by deamidation in 
proteases.  
 
2.4 Material and Methods 
All chemicals were of analytical-reagent grade or higher quality and were purchased 
from Sigma-Aldrich (Taufkirchen, Germany) and Applichem (Darmstadt, Germany). 
All enzymes were purchased from Fermentas (St. Leon-Rot, Germany) and New 
England Biolabs (Frankfurt, Germany). Thermal cycler (Eppendorf Mastercyler proS, 
Hamburg, Germany) and thin-wall PCR tubes (Multi-ultra tubes, 0.2 mL, Carl Roth, 
Karlsruhe, Germany) were used in all PCRs. The PCR volume was always 25 µL. 
The amount of DNA in cloning experiments was quantified by using a NanoDrop 
photometer (Thermo Scientific NanoDrop1000, Braunschweig, Germany). 
2.4.1 Bacillus gibsonii alkaline protease (BgAP) 
BgAP gene along with its pre-pro-sequence including the Bacillus promoter was 
inserted into the pHY300PLK shuttle vector (Takara Bio Inc, Shiga, Japan). The 
generated construct was named pHYBgAP. BgAP gene is translated into a 
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270 amino acid mature protease with a size of approximately 27 kDa. As an alkaline 
protease, BgAP has an optimum pH of 11 (Siegert et al. 2009). 
2.4.2 Sequence alignment 
The sequence alignment of 15 BgAP related proteases having an amino acid identity 
ranging from 79 % to 31 % according to BLASTP (Altschul et al. 1997; PDB code: 
1MPT [79 %], 1SVN [79 %], 1AH2 [78 %], 1C3L [56 %], 1SIB [55 %], 1SCJ [54 %], 
1GNS [51 %], 1DBI [47 %], 1THM [45 %], 2XRM [41 %], 2Z2X [40 %], 2IXT [40 %], 
2GKO [39 %], 2ID8 [37 %], 1WMD [31 %]) was performed with the multiple sequence 
alignment function of Clone Manager 9 Professional Edition (Sci-Ed software, Cary, 
USA). Residues were defined as not conserved with an identity of less than 60 % in 
the alignment. 
2.4.3 Site-directed mutagenesis 
Site-directed mutagenesis of BgAP was performed as previously described (Wang 
and Malcolm 1999) at 18 selected sites on BgAP in the pHYBgAP construct. The site 
specific primers are listed in Table 2. 
For the site-directed mutagenesis PCR (First stage: 98°C for 30 s, 1 cycle; 98°C 
10 s/55°C, 30 s/72°C, 2 min, 4 cycles. Second stage: 98°C for 30 s, 1 cycle; 98°C, 
10 s/55°C, 30 s/72°C 3 min, 12 cycles; 72°C for 3 min, 1 cycle), PhuS DNA 
Polymerase (2 U), 0.20 mM dNTP mix, 0.2 µM of each primer together with template 
(20 ng; pHYBgAP) were used. Following the PCR, DpnI (20 U; New England Biolabs) 
was supplemented for template digestion, and incubated overnight at 37°C. The DpnI 
digested PCR products were purified by using a NucleoSpin Extract II Purification Kit 
(Macherey-Nagel, Düren, Germany) and transformed into E. coli DH5α (Inoue et al. 
1990). The E. coli DH5α mutants were cultivated (250 rpm, 37°C, 16 h) and plasmids 
were isolated using a NucleoSpin Plasmid Kit (Macherey-Nagel) followed by 
transformation into protease deficient B. subtilis DB104 strain (nprR2 nprE18 and 
ΔaprA3; Kawamura and Doi 1984; Vojcic et al. 2012) for extracellular BgAP 
production. 
2.4.4 Cell culture and expression 
Expression of the generated protease variants in B. subtilis DB104 was performed in 
microtiter plates (Greiner, Frickenhausen, Germany). For expression buffered LB 
media (pH 7.6; 1 % (w/v) tryptone, 0.5 % (w/v) yeast extract and 1 % (w/v) sodium 
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chloride, 17 mM potassium dihydrogen phosphate, 72 mM dipotassium hydrogen 
phosphate) was used. The volume of 10 µL preculture (200 µL, 900 rpm, 37°C, 18 h, 
and 70 % humidity) was used to inoculate the mainculture (150 µL, 900 rpm, 37°C, 
24 h, and 70 % humidity). The protease was separated from the cells by 
centrifugation (Eppendorf 5810R; 4°C, 3,220 g, 20 min) and the obtained protease 
containing supernatant was used for analysis. 
Table 2: Primers used for site-directed mutagenesis of the BgAP gene. 
Position Sequence (5‘ to 3‘) 
F_N60D GTCAACAACGGCTGATCTAGATGGTCATGGTACTC 
R_N60D GAGTACCATGACCATCTAGATCAGCCGTTGTTGAC 
F_N97D TAAAGGTCCTAGGAGCAGATGGTAGAGGAAGCGTG 
R_N97D CACGCTTCCTCTACCATCTGCTCCTAGGACCTTTA 
F_N115D CTAGAGTGGGCTGCAACGGATAACATGCATATTGC 
R_N115D GCAATATGCATGTTATCCGTTGCAGCCCACTCTAG 
F_N154D GCGGCTACCGGTAACGATGGTACTGGTTCCA 
R_N154D TGGAACCAGTACCATCGTTACCGGTAGCCGC 
F_N167D GCTACCCAGCTCGTTATGCAGACGCAATGGC 
R_N167D GCCATTGCGTCTGCATAACGAGCTGGGTAGC  
F_N205D GAATACAAAGCACATACCTAGATAATAGCTATGCTAGTATGCCTG 
R_N205D CAGGCATACTAGCATAGCTATTATCTAGGTATGTGCTTTGTATTC 
F_N236D GTTAAACAAAAAAATCCATCTTGGGATGCGACTCAAATTCGTAATC 
R_N236D GATTACGAATTTGAGTCGCATCCCAAGATGGATTTTTTTGTTTAAC 
F_N242D GAATGCGACTCAAATTCGTGATCATTTGAAAAATACTGCGAC  
R_N242D GTCGCAGTATTTTTCAAATGATCACGAATTTGAGTCGCATTC 
F_N250D CATTTGAAAAATACTGCGACGGATCTAGGAAACTCATCTC 
R_N250D GAGATGAGTTTCCTAGATCCGTCGCAGTATTTTTCAAATG 
F_N253D CTGCGACGAATCTAGGAGACTCATCTCAATTTGGTAG 
R_N253D CTACCAAATTGAGATGAGTCTCCTAGATTCGTCGCAG 
F_Q12E CATGGGGTATTACACGTGTAGAGGCTCCCACTGTGCATAATC 
R_Q12E GATTATGCACAGTGGGAGCCTCTACACGTGTAATACCCCATG 
F_Q37E GCTATACTTGATACAGGTATAGCTGAGCATAGTGATTTAAC 
R_Q37E GTTAAATCACTATGCTCAGCTATACCTGTATCAAGTATAGC 
F_Q107E CGTGAGTGGGATTGCTGAGGGTCTAGAGTGGGC  
R_Q107E GCCCACTCTAGACCCTCAGCAATCCCACTCACG 
F_Q176E CTGTAGGAGCGACTGACGAGAACAACAGACGTGCGAG 
R_Q176E CTCGCACGTCTGTTGTTCTCGTCAGTCGCTCCTACAG 
F_Q185E GACGTGCGAGCTTTTCTGAGTATGGCACAGGAATTG 
R_Q185E CAATTCCTGTGCCATACTCAGAAAAGCTCGCACGTC 
F_Q200E GCACCTGGTGTTGGAATAGAGAGCACATACCTAAATAATAGC  
R_Q200E GCTATTATTTAGGTATGTGCTCTCTATTCCAACACCAGGTGC 
F_Q230E GGAGTAGCTGCGCTTGTTAAAGAGAAAAATCCATCTTGGAATGCG 
R_Q230E CGCATTCCAAGATGGATTTTTCTCTTTAACAAGCGCAGCTACTCC 
F_Q256E CTAGGAAACTCATCTGAGTTTGGTAGTGGACTAG 
R_Q256E CTAGTCCACTACCAAACTCAGATGAGTTTCCTAG 
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2.4.5 Skim milk detection system 
The volume of 190 µL of substrate solution (2 % skim milk, 100 mM Tris/HCl, pH 8.6) 
was transferred in each well (flat bottom microtiter plates; Greiner, Frickenhausen, 
Germany) and 10 µL of supernatant were supplemented for quantification of 
proteolytic activity of secreted BgAP and BgAP variants. Protease activity was 
monitored by the decrease in absorbance with the a microtiter plate reader (650 nm, 
23°C; Tecan Sunrise, Crailsheim, Germany). The decrease on absorbance at 
650 nm across 5 min of incubation at 23°C was measured in Absorbance Units per 
min (AU/min). 
2.4.6 Residual activity assay for thermal resistance 
Thermal inactivation of protease variants in the cell culture supernatant was 
performed by incubating 25 µL of supernatant for 10 min at 60°C (Eppendorf 
Mastercyler proS). Residual activity was detected by using the skim milk detection 
system described in the previous paragraph. The residual activity (%) was defined as 
the activity (AU/min) of the thermal treated sample divided by the activity (AU/min) of 
the untreated sample, represented in percent. 
2.4.7 Native polyacrylamid gel electrophoresis 
Native gels (GE Healthcare, PhastGel Gradient, 8-25 % acrylamide, 112 mM acetate, 
112 mM Tris, pH 6.4, Freiburg, Germany) and buffers (GE Healthcare, PhastGel 
Buffer Strips Native, 0.88 M L-alanine, 0.25 M Tris, pH 8.8) were used for protein 
electrophoresis to analyse the charge differences of BgAP and its variants. The 
separation was accomplished in the PhastSystem (GE Healthcare, PhastSystem 
Automated Electrophoresis Development Unit) at 15°C with reversed polarity of the 
electrodes. The protease bands were visualized using an activity overlay detection 
system with a gelatine photographic film (Paech et al. 1993).  
2.4.8 Production and purification of BgAP and variants 
BgAP and its variants were subcloned into a high-expression vector (provided by 
Henkel AG & Co. KGaA) and transformed into B. subtilis DB104. Production of BgAP 
and its variants was accomplished in shaking flasks (500 mL) using MLBSP media 
(100 mL, 180 rpm, 37°C, 48 h; Wilson et al. 1999). A clear supernatant was obtained 
after centrifugation (Eppendorf 5810R, 3,220 g, 40 min, 4°C). The clear supernatant 
was dialyzed in HEPES buffer (9 L, pH 7.8, 20 mM, 4°C, 14 h) using a dialysis 
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membrane with a 3.5 kDa cut off (Spectrum Spectra/Por 3, Breda, Netherlands). The 
conductivity was, if required, adjusted to 1.2 mS/cm with demineralized water. 
The dialysed supernatant was loaded into an anion exchange chromatography 
column (GE Healthcare Q Sepharose Fast Flow; equilibrated with HEPES buffer 
(pH 7.8, 20 mM) which was connected in series to a cation exchange column (GE 
Healthcare SP Sepharose Fast Flow; equilibrated with HEPES buffer (pH 7.8, 
20 mM). The flow rate and pressure were monitored by an ÄKTAexplorer (GE 
Healthcare). The anion exchange column acts as a “negative purification” and BgAP 
or its variants bound to the cation exchange column at pH 7.8. For elution of BgAP 
the anion exchange column was disconnected and a linear gradient of sodium 
chloride up to 1 M in HEPES buffer (pH 7.8, 20 mM) was used to elute the absorbed 
proteins from the cation exchange column. The peak fractions were pooled together. 
Protein concentration of purified BgAP variants was normalized by measuring the 
total protein concentration using the BCA protein assay kit (Thermo Scientific) and 
the Experion System (Experion Pro260 chip; Bio-Rad Laboratories Experion 
Automated Electrophoresis System, München, Germany). 
2.4.9 pH-activity profile of purified BgAP and variants 
Proteolytic activity on macromolecular substrate was assessed using azo-dye 
labelled collagen, as previously reported (Chavira et al. 1984). Azocoll 
(Merck/Calbiochem AzocollTM MESH >100, Darmstadt, Germany) was used in final 
concentrations of 1 % (w/v) in 100 mM glycin and a pH range of 8.5 to 12 with 
adjustments made using 2 M NaOH and HCl. The proteolytic assay was performed in 
V-bottom microtiter plates (Corning, Wiesbaden, Germany) with protease 
concentrations of 40 nM. After reaction (Eppendorf Thermomixer comfort; 700 rpm, 
25 min, 40°C) the samples were incubated for 1 min on ice and centrifuged 
(Eppendorf 5810 R; 3,220 g, 20 min, 4°C). The absorbance of released azo-dye in 
100 µL supernatant was detected at 520 nm in a Tecan Sunrise using flat bottom 
microtiter plates (Greiner). 
The complete digestion of 1 mg substrate resulted in an absorbance value at 520 nm 
of 1,506. One unit was defined as the enzyme activity producing an increase in 
absorbance of 1.0 per minute at pH 9.5 in 100 mM glycine/NaOH buffer. One unit 
corresponded to the digestion of 0.664 mg substrate. 
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2.4.10 Thermal resistance of purified BgAP and variants 
Thermal inactivation was monitored by incubating BgAP and its variants (3.5 µg/mL; 
20 min) at various temperatures in a thermal cycler (Eppendorf Mastercyler proS, 
gradient 46 - 62°C) in 100 mM Glycin/NaOH buffer (pH 8.5 and pH 10.5, 25 µL) and 
250 mg/mL bovine serum albumin as an additive to prevent self-digestion. Residual 
activity was detected by using the skim milk detection system. The enzymes 
incubated on ice were considered to be the control and represent 100 % activity. 
2.4.11 Homology modelling and surface residue determination 
The three-dimensional structure model for BgAP was generated using the homology 
model routine from YASARA (Krieger et al. 2002) based on the coordinates of a 
serine protease from Bacillus lentus (PDB ID: 1GCI, Kuhn et al. 1998) YASARA was 
used for visualization of the molecular structures. The surface residues of the 
generated BgAP model were determined using Discovery Studio 3.1 Visualizer 
Software (Accelrys, Inc., San Diego, USA) using the solvent accessibility dialog. A 
residue was defined as “exposed” or “buried” if the solvent accessibility was greater 
than 25 % or less than 10 % of the maximum solvent accessibility, respectively. 
 
2.5  Results 
The results section is divided in four parts: 2.5.1 Screening of proteolytic activity and 
thermal resistance, 2.5.2 Net charge difference analysis of BgAP and its variants, 
2.5.3 pH-dependent activity profile of purified BgAP and its variants, and 2.5.4 
Thermostability profiles of purified BgAP and its variants. 
2.5.1 Screening of proteolytic activity and thermal resistance 
All generated variants were constructed as described in chapter 2.4 Materials and 
Methods. For the selection of the targeted Asn and Gln residues the following 
selection criteria were defined: (1) surface exposed, (2) not conserved, and (3) 
neighboured by a glycine residue three amino acids up- or downstream from the 
targeted Asn or Gln residue. The third selection criteria rose empirically and is based 
on the deamidation promoting property of a glycin one amino acid sequence 
upstream of the target Asn or Gln (Kossiakoff 1988). 
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Figure 5 categorizes all Asn and Gln residues found in BgAP according to the three 
defined selection criteria. The underlined positions, a subset of in total 18 positions 
fulfilling at least two selection criteria, were subjected to site-directed mutagenesis 
and analyzed in microtiter plate format. 
 
Figure 5: Representation of all asparagine and glutamine residues present in BgAP assigned to the 
three defined selection criteria (Not conserved residues, Surface exposed residues, and Residues 
neighboured by glycine). The selected and by site-directed mutagenesis mutated positions are 
underlined. 
Variants having the substitutions N60D (surface exposed and neighbored by glycine) 
and Q185E (not conserved and neighbored by glycine) fulfill only two selection 
criteria and resulted in decreased proteolytic activity (N60D) or in an inactive variant 
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(Q185E). For both variants no residual activity was detected after thermal treatment 
(10 min, 60°C). 
The selection criteria surface exposed (1) and not conserved (2) are fulfilled by 16 
positions. A subset of eight positions was selected and substituted. Six variants 
(N205D, N236D, N242D, Q12E, Q176E and Q230) showed proteolytic activities in 
the range of wt-BgAP (±18 %). Variant N115D was inactive and variant N167D 
showed a decrease in proteolytic activity of 23 % compared to wt-BgAP. In case of 
thermal resistance, two variants (N205D and Q12E) showed a decrease in residual 
activity of more than 16 %; however, the majority of the generated variants (N167D, 
N236D, N242D, and Q176E) were in the range of wt-BgAP (±10 %). An exception for 
this group is variant Q230E, which showed an increased thermal resistance of 22 % 
compared to wt-BgAP. 
Nine residues were identified which fulfill all three defined selection criteria (surface 
exposed, not conserved and neighbored by glycine). Out of these nine targetable 
residues, eight variants were generated and tested. Variant Q107E showed 47 % 
decreased proteolytic activity compared to wt-BgAP and variants N154D and N250D 
were proteolytically as active as wt-BgAP. The remaining five variants (N97D, 
N253D, Q37E, Q200E and Q256E) showed a more than 25 % increased proteolytic 
activity compared to wt-BgAP. The variants Q37E, N253D and N97D showed with 
36 %, 35 % and 46 % the strongest increase in proteolytic activity, whereas variants 
Q200E and Q256E showed a moderate increase in proteolytic activity (25 % and 
29 %). The aforementioned increase in activity was not observed in variants that did 
not fulfill all three defined selection criteria (Table 3). 
Regarding thermal resistance, the majority of the generated variants (N97D, N250D, 
Q37E, Q107E and Q200E) had a comparable residual activity to wt-BgAP (±10 %), 
except variant N154D (12 % residual activity and less stable than wt-BgAP). Variants 
N253D and Q256E showed a moderately residual activity (84 % and 71 %) and a 
significantly higher thermal resistance than the wt-BgAP (Table 3). 
Variants N253D and Q256E were finally selected for detailed characterization due to 
their simultaneous increase in proteolytic activity and thermal resistance when 
compared to wt-BgAP. In addition, the double mutant N253DQ256E was generated 
to study possible cooperative or additive effects. 
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Table 3: Proteolytic activity of BgAP and muteins before and after thermal treatment. Proteolytic 
activity was determined from the clear supernatant of B. subtilis DB104 cultures using the skim milk 
activity detection system (2 % (w/v) skim milk, 100 mM Tris/HCl pH 8.6). The residual proteolytic 
activity (%) was defined as the activity (AU/min) of the thermal treated sample (10 min, 60°C) divided 
by the activity (AU/min) of the untreated sample, represented in percent. The muteins are sorted by 
the conformance of the three selection criteria. 
 
 
Relative proteolytic activity Residual proteolytic activity 
 
 
[% of wt-BgAP] [% of initial activity] 
 WT 
 
100 ± 5 % 
  
38 ± 5 % 
 
Surface exposed and neighbored by glycine 
 N60D 
 
32 ± 14 % 
  
not active* 
 
Not conserved and neighbored by glycine 
 Q185E 
 
not active* 
  
not active* 
 
Surface exposed and not conserved 
 N115D 
 
not active* 
  
not active* 
 
 N167D 
 
77 ± 5 % 
  
28 ± 6 % 
 
 N205D 
 
113 ± 7 % 
  
16 ± 3 % 
 
 N236D 
 
115 ± 2 % 
  
35 ± 6 % 
 
 N242D 
 
118 ± 7 % 
  
31 ± 5 % 
 
 Q12E 
 
114 ± 8 % 
  
13 ± 1 % 
 
 Q176E 
 
97 ± 2 % 
  
36 ± 2 % 
 
 Q230E 
 
107 ± 8 % 
  
50 ± 5 % 
 
Surface exposed, not conserved and neighbored by glycine 
 N97D 
 
146 ± 3 % 
  
44 ± 2 % 
 
 N154D 
 
107 ± 4 % 
  
12 ± 5 % 
 
 N250D 
 
113 ± 8 % 
  
45 ± 6 % 
 
 N253D 
 
135 ± 4 % 
  
84 ± 4 % 
 
 Q37E 
 
136 ± 1 % 
  
38 ± 5 % 
 
 Q107E 
 
53 ± 8 % 
  
32 ± 5 % 
 
 Q200E 
 
125 ± 7 % 
  
45 ± 6 % 
 
 Q256E 
 
129 ± 4 % 
  
71 ± 3 % 
 
 
*no activity detected under the defined conditions 
 
 
2.5.2 Net charge difference analysis of BgAP and variants 
The decreased positive net charge of N253D, Q256E and N253DQ256E was 
confirmed by native polyacrylamide gel electrophoresis (Figure 6) in which proteolytic 
activity was visualized using a gelatin-film overlay (Paech et al. 1993). 
Figure 6 shows distinct protein bands representing the different net charges of wt-
BgAP, variants with Δ-1 (N253D or Q256E) and Δ-2 (N253DQ256E). The BgAP-
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protease and variants are overall positively charged in the native gel at pH 6.4 and 
the migration distance is decreased with reduced positive net charge.  
 
Figure 6: Native polyacrylamide gel electrophoresis and gelatin-film activity overlay of wt-BgAP and its 
variants (N253D, Q256E and N253DQ256E) which differ in the positive net charge. 
 
2.5.3 pH-dependent activity profile of purified BgAP and variants 
Figure 7a shows the pH dependence of the proteolytic activity profiles of purified wt-
BgAP, N253D, Q256E and N253DQ256E which was determined using the Azocoll 
proteolytic assay (pH range 8.5 to 12; 100 mM Glycin/NaOH buffer).The Azocoll 
assay is reliable over a broad pH range, whereas skim milk spontaneously 
hydrolyzes at high alkaline conditions. BgAP shows an activity profile with a 
maximum at pH 11. The activity of BgAP at pH 8.5 and pH 12.0 was decreased to 
50 % and 83 %, respectively. Variants N253D and Q256E showed equal pH 
dependence but differ from wt-BgAP since their pH-activity optimum is shifted by one 
unit to pH 10.0, without losing specific activity (Figure 7a,b). The activity of N253D 
and Q256E is reduced to 71 % and 72 % of the maximum at pH 8.5 and pH 12.0 
respectively. The double mutant N253DQ256E shows also a shift on the pH-activity 
optimum from pH 11 to pH 10, with comparable specific activity to wt-BgAP at pH 11. 
The pH dependent activity of N253DQ256E is reduced to 90 % and 73 % at pH 8.5 
and pH 12.0 respectively (Figure 7a,b). The pH-activity profiles are in general shifted 
with reduced positive net charge to lower pH values leading to higher activities at 
reduced pH and reduced activity at alkaline pH.  
Figure 7c shows that, normalized on the wt-BgAP activity, the residual pH-activity 
dependence of the muteins N253D, Q256E and N253DQ256E at a pH range from 
8.5 to 12.0. Variants N253D and Q256E show a higher activity compared to wt-BgAP 
at pH values lower than 10. The wt-BgAP has at alkaline conditions pH >10 a 
superior proteolytic activity than N253D and Q256E. 
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Figure 7: (  wt-BgAP,  N253D,  Q256E, and  N253DQ256E): a) pH-activity profile as percentage 
of maximum activity of each variant, b) Specific proteolytic activity determined with the Azocoll 
detection system (520 nm); inserted Figure shows the linear detection range of the Azocoll system, 
and c) Relative specific proteolytic activity as percentage of wt-BgAP activity at varied pH values. For 
activity measurements were employed 40 nM of wt-BgAP/muteins and 1 % (w/v) Azocoll in 100 mM 
glycin/NaOH buffer (pH 8.5 to 12). After 25 min incubation at 40°C and 20 min centrifugation at 
3,220 g the absorbance of the supernatant was measured at 520 nm. Three measurements showed a 
standard deviation below 15 %. 
The double mutant N253DQ256E shows at pH higher than 11 a nearly identical 
proteolytic activity compared to the single mutants. On the other hand, at lower pH 
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values the proteolytic activity exceeds significantly the values of the corresponding 
single mutants N253D and Q256E. At pH 8.5 N253DQ256E shows a ~2.0-fold 
improvement in specific activity compared to wt-BgAP activity. 
2.5.4 Thermostability profiles of purified BgAP and variants 
Figure 8a and b show the residual activity of purified wt-BgAP, N253D, Q256E and 
N253DQ256E after 20 min incubation at different temperatures and at two pH values 
(pH 8.5 and 10.5). The generated variants showed a residual activity improvement of 
~28 % and ~37 % over wt-BgAP after being incubated at 53.2°C and 55.4°C (20 min; 
pH 8.5). When incubated at pH 10.5, the average residual activity of the BgAP 
muteins was improved by ~23 % and 18 % compared to wt-BgAP (51.1°C and 
53.2°C; 20 min). 
The T50 value is defined as the temperature at which the residual activity equals 50 % 
of the initial proteolytic activity after 20 min incubation at varied temperatures 
(gradient 46-62°C) in Glycin/NaOH buffer (100 mM, pH 8.5 and pH 10.5). 
The thermostability constant T50 of wt-BgAP and the variants is lowered by 3-4°C at 
pH 10.5 when compared to pH 8.5. At pH 8.5, the T50-value for N253D, Q256E and 
N253DQ256E was found to be increased by 2.3°C, 2.2°C and 2.5°C, in case of 
pH 10.5 the differences were determined to be 1.1°C, 1.6°C and 1.4°C respectively 
(Table 4). 
 
Figure 8: Residual enzyme activity of wt-BgAP, N253D, Q256E and N253DQ256E: a) after being 
incubated at 51.1°C (black), 53.2°C (grey) and 55.4°C (white) at pH 8.5 for 20 min, b) after being 
incubated at 49.2°C (black dashed), 51.1°C (grey dashed) and 53.2°C (white dashed) at pH 10.5 for 
20 min. Heat incubation was performed with 4 µM of wt-BgAP and muteins (N253D, Q256E, 
N253DQ256E) for 20 min in 100 mM Glycin/NaOH buffer at pH 8.5 and 10.5 and 250 mg/mL bovine 
serum albumin. Residual activity was measured with the skim milk detection system (2 % (w/v) skim 
milk, 100 mM Tris/HCl, pH 8.6). 
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Table 4: The calculated T50 values of wt-BgAP, N253D, Q256E and N253DQ256E are defined as the 
temperature at which 50 % of the initial activity is retained after 20 min incubation (100 mM 
Glycin/NaOH, pH 8.5 or pH 10.5, no additional CaCl2 supplemented). Average values of two 
independent measurements are shown and deviations are calculated from the fitted sigmoidal curves. 
Mutant 
 pH 8.5  pH 10.5 
 
T50 [°C] Increase [°C] 
 
T50 [°C] Increase [°C] 
Wt-BgAP  53.4 ± 0.3 -   50.5 ± 0.1  - 
N253D  55.6 ± 0.3 2.2  51.6 ± 0.2  1.1 
Q256E  55.6 ± 0.1 2.2  52.0 ± 0.1  1.5 
N253DQ256E 
 
55.8 ± 0.2 2.4 
 
51.8 ± 0.2  1.3 
 
2.6 Discussion 
Enzymatic and non-enzymatic deamidation has proven to have a significant influence 
on enzyme properties like activity, thermal resistance and pH optimum (Capasso et 
al. 1989; Catak et al. 2009; Kato et al. 1987a; Kato et al. 1987b; Kato et al. 1992; 
Robinson and Robinson 2004). In all these reports enzyme properties were altered 
by an increasing number of negatively charged surface residues. The three selection 
criteria to target surface residues represent a straight forward and empirical 
sequence alignment-based strategy to identify Asn and Gln residues which can 
preferentially be targeted for deamidation by site-directed mutagenesis to improve 
activity, thermal resistance or to shift pH optima. The intention was not to simulate or 
to study factors which affect the naturally occurring deamidation reaction. The aim 
was to study the effect of the introduced negative charges to properties of the BgAP 
protease. The substitutions of the deamidation type (Asn → Asp, Gln → Glu) have 
accordingly to the BLOSUM62 matrix a score of one and two, respectively (Henikoff 
and Henikoff 1992) so that the generated variants harboring substitutions of the 
deamidation type should remain active. The three proposed selection criteria 
dramatically reduce the potentially targetable residues to introduce negative charges. 
The first selection criterion of excluding Asn and Gln residues which are not exposed 
to the surface will further reduce the number of inactive enzyme variants, as 
demonstrated with variant Q185E which was not surface exposed and inactive 
(Table 3). 
In a second step non-conserved Asn and Gln residues are determined through 
sequence alignment with related subtilisin proteases to exclude structurally important 
positions. In the third step Asn and Gln residues are preferred which are neighbored 
SURFACE CHARGE ENGINEERING 
25 
 
by a deamidation promoting amino acid within three amino acids up- or downstream 
on the sequence (like glycine; Bodanszky and Kwei 1978; Kossiakoff 1988; Teshima 
et al. 1991). The third selection criterion rose empirically and increases the chance to 
identify protease variants with an altered pH-profile or increased thermal resistance. 
The protease BgAP consists of 270 amino acids out of which 113 amino acids are 
surface exposed. The surface amino acids include 31 Asn and Gln residues, wherein 
26 residues are not conserved. Only 9 not conserved residues are neighbored by a 
glycine (three amino acids up- or downstream). By applying our developed selection 
criteria and the “deamidation type” substitution pattern (Asn → Asp, Gln → Glu) only 
nine variants have to be generated and studied in order to shift and improve pH 
dependent activity and thermal resistance of BgAP (compare Figure 5 and Table 3). 
Out of these nine variants eight were generated and investigated. Five variants had 
an increased proteolytic activity at pH 8.6. Two of the generated variants (N253D, 
Q256E) fulfill all three selection criteria and show a strong increase in thermal 
resistance when compared to wt-BgAP (Table 3). 
Out of the 18 Asn and Gln residues that don’t fulfill the third criterion (neighboured by 
glycine) 10 corresponding variants were generated, resulting in no variant with 
increased proteolytic activity when compared to wt-BgAP. Only one variant (Q230E) 
had an increased residual activity after thermal treatment when compared to wt-
BgAP. The two variants N60D (conserved) and Q185E (not surface exposed) 
showed as expected decreased or no proteolytic activity when compared to wt-BgAP.  
A success rate of five out of eight modifications, resulting in an increased proteolytic 
BgAP activity, proves that sequence alignment-based deamidation of rational 
selected positions by site-directed mutagenesis represents a successful approach to 
improve activity by surface charge engineering.  
Due to the extent of improvements, positions N253D, Q256E and combination 
N253DQ256E were finally selected for detailed characterization in terms of: a) activity 
increases (Figure 7b,c,) influences on  pH-optima (Figure 7a), and c) thermal 
resistance improvements (Table 4, Figure 8). Substitutions N253D and Q256E are 
located on the same loop and N253DQ256E was generated to study possible 
cooperative or additive effects.  
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Deamidated variants showed up to 2.4°C increased T50 for N253DQ256E at pH 8.5. 
No additive or cooperative effect could be observed when compared to the individual 
single mutant Q256E and N253D (Table 4, Figure 8). Wt-BgAP and the three 
deamidated variants showed at pH 10.5 a lower increase in thermal resistance 
compared to pH 8.5, but still significant. The determined residual activity is an 
indicator for thermal stability since the mature BgAP protease is not capable to refold 
correctly in absence of the pro-peptide (Siezen and Leunissen 1997). 
The pH activity profiles were determined using an azo-dye labeled collagen as a 
substrate. Azo-dye labeled collagen is a complex protease substrate and close to 
application conditions in the detergent industry and therefore a better choice than 
short chain peptides with chromogenic or flourogenic cleaving site. The pH activity 
profiles for deamidated variants (N253D, Q256E, and N253DQ256E) were 
significantly shifted with a general trend towards higher proteolytic activity at lowered 
pH values resulting in a pH-optimum shift from 11 to 10. The single muteins (N253D 
and Q256E) show similar pH profile shifts. The combined variant N253DQ256E loses 
at pH 8.5 only ~10 % of its activity whereas as the single mutants have a ~30 % and 
the wt-BgAP has a 50 % reduced activity (Figure 7). Figure 7c shows that the relative 
improvement in specific proteolytic activity for the double mutant exceeds the additive 
effects of the two single mutants. The latter result suggests that negative charges on 
surface could cause an increase in proteolytic activity through additive and/or 
cooperative effects. 
The effects of modifying surface charges on the catalytic activity of a thermolysin-like 
protease (pH-optimum: ~6.8) by inserting or removing charges on the protein surface 
were studied previously. Significant changes were observed in the activity of the 
thermolysin-like protease even when amino acid substitutions were as much as 25 Å 
apart from the active site (De Kreij et al. 2002).  
In our case, the finally studied amino acid substitutions (N253D, Q256E, 
N253DQ256E) are located in a loop which is not close to the active site, however 
activity as well as thermal resistance were increased. A similar observation has been 
reported for other proteases by Miyazaki et al., where the thermostability and low 
temperature activity of a psychrophilic subtilisin S41 was enhanced by directed 
evolution. The introduced mutations were, similar to our findings, far from the active 
site, and located in the outer loops of the protease (Miyazaki et al. 2000). The 
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substitutions generated in BgAP will likely cause electrostatic long range interactions 
which are challenging to be addressed by computational modeling since structural 
changes that are related to increased protein stability are commonly described to 
cause reinforcement on the overall structural rigidity, which most likely goes along 
with a decrease in catalytic performance. The challenge for a molecular 
understanding lies in the build-up of a model in which the flexibility, as prerequisite for 
high activity, has to be maintained or improved around the active site whereas global 
motions have to be reduced in regions at which unfolding occurs (Martinez et al. 
2011).  
In essence, a novel protein engineering approach was developed, independent or 
additive to other methods, to optimize protein properties like activity, thermal 
resistance and pH optima through surface charge engineering and “simulated” 
deamidation by site-directed mutagenesis.  
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3 DIRECTED PROTEASE EVOLUTION TOWARDS INCREASED INHIBITION BY 
BENZYLMALONIC ACID  
 
3.1 Objective 
The aim of this project was the identification of Bacillus lentus alkaline protease 
(BLAP) variants showing an increased inhibition towards benzylmalonic acid 
compared to the BLAP parent. Subsequently, the structure-function relationships 
were investigated to identify inhibitor-protease interactions, which could be 
responsible for increased inhibition. The target was to increase the inhibition of BLAP 
by benzylmalonic acid in order to match the performance of the industrial standard 
boric acid. 
 
3.2 State of the art 
3.2.1 Inhibitors and subtilisins used in liquid detergent applications 
The use of enzymes in laundry detergents as extremely effective catalysts represents 
the largest field of industrial enzyme applications. Among others, proteases, lipases, 
amylases and cellulases are supplemented into detergent formulations for the 
efficient removal of specific stains (Kirk et al. 2002). In 2004, less than 15 different 
protease molecules were used in detergents worldwide, being all subtilisin proteases 
originated from Bacillus sp. (e.g. Bacillus licheniformis, Bacillus clausii, Bacillus 
lentus, Bacillus alkaloophilus, and Bacillus halodurans).  Among these, proteases 
originated from Bacillus lentus (e.g. BLAP S and BLAP X) represented one third of 
the industrially used subtilisins (Maurer 2004). These enzymes are stable towards 
high temperature, high pH and surfactants used in liquid detergents. Proteases 
represent the major enzymatic component in detergents implying unspecific autolysis 
and proteolysis of enzymatic components during storage (Stoner et al. 2004). The 
optimization of stabilization and inhibition of the supplemented proteases is 
nowadays an interesting research field (Lund et al. 2011; Daugherty et al. 2012; 
Smoum et al. 2012) and is commercially accomplished by the addition of boron 
containing inhibitors e.g. boric acid (Severson 1985) or 4-formylphenylboronic acid 
(Nielsen and Deane-Wray 1999). The importance of inhibitors in detergents to 
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stabilize enzymes is illustrated by the fact that 6,400 tons of boric acid were used in 
the European market in 2004 explicitly for detergent applications (Human and 
Environmental Risk Assessment on ingredients of Household Cleaning Products 
(HERA); http://www.heraproject.com).  
The major drawback of boric acid is its toxic potential, which was reported in long-
term studies showing critical effects on male reproductive toxicity and developmental 
toxicity, when consumed in high doses (a 60 kg person would need to consume daily 
3.3 g boric acid; Hubbard 1998). However, exposure to boric acid in detergent 
products under normal handling and use, by consumers’ are very low (0.0453 µg 
boric acid/kg bw/day; HERA). The elimination of boron from liquid laundry detergents 
is nevertheless an interesting industrial and scientific objective.  
In therapeutic studies, the identification of novel inhibitors for target enzymes is 
accomplished by the screening of enormous drug-like molecule libraries. As an 
example, out of 50,000 drug-like small molecules, five novel molecules were 
identified which efficiently inhibit the main proteinase of SARS-CoV 3CLpro using a 
fully automated screening system (Blanchard et al. 2004). 
Engineering recombinant target enzymes towards increased inhibition is an 
alternative to screening of immense libraries to inhibit detergent proteases. The 
favored tool to engineer novel protein properties with an unsolved mechanism is 
directed protein evolution. In 2004 the half of the commercially used detergent 
subtilisin proteases were protein engineered variants (Maurer 2004). A typical 
experiment comprises three major steps: (1) diversity generation, (2) screening to 
identify improved mutants out of a large pool of variants, and (3) isolating the gene 
encoding for the improved protein variants. These genes are subsequently used in 
iterative cycles of diversity generation and screening until the targeted improvement 
has hopefully been reached (Tee and Schwaneberg 2007; Figure 3).  
 
3.3 Material and Methods 
All chemicals were of analytical-reagent grade or higher quality and were purchased 
from Carl Roth GmbH (Karlsruhe, Germany), Sigma-Aldrich (Hamburg, Germany), 
Bachem (Bubendorf, Switzerland) and AppliChem (Darmstadt, Germany). 
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Oligonucleotides were purchased from Eurofins MWG Operon (Ebersberg, Germany) 
in salt-free form. Enzymes were purchased from New England BioLabs (Frankfurt am 
Main, Germany). Plasmid extraction and PCR purification kits were purchased from 
Macherey-Nagel (Düren, Germany). Microtiter plates (Greiner Bio-One GmbH, 
Frickenhausen, Germany) were incubated in a Microtron Infors shaker (Infors AG, 
Bottmingen, Switzerland). DNA concentrations were quantified using a NanoDrop 
photometer (Thermo Scientific NanoDrop1000, Braunschweig, Germany). A 
Mastercycler gradient (Eppendorf, Hamburg, Germany) and thin-wall PCR tubes 
(Multi ultra-tubes; 0.2 mL; Carl Roth, Germany) were used in all PCRs. 
3.3.1 Bacillus lentus alkaline protease (BLAP) 
The used Bacillus lentus alkaline protease (BLAP) gene codes for a 269 amino acid 
mature protease (BLAP, PDB: 1ST3A) and has a molecular weight of ~27 kDa. The 
BLAP parent contained two amino acid substitutions at positions G1A and R99E 
compared to the literature described BLAP (PDB ID: 1ST3; Goddette et al. 1992). 
The BLAP gene was contained in an industrial expression vector (pHKL) suitable for 
high level extracellular protease production in Bacillus subtilis DB104 (Kawamura and 
Doi 1984). The pHKLBLAP construct was kindly provided by Henkel AG & Co. KGaA 
(Düsseldorf, Germany). 
3.3.2 Generation of Sequence Saturation Mutagenesis (SeSaM) libraries 
Random mutagenesis libraries and DNA recombination of BLAP gene was performed 
using the Sequence Saturation Mutagenesis method (SeSaM; SeSaM-Biotech, 
Bremen, Germany) followed by the insertion of the modified genes in the pHKL 
vector using PLICing (Blanusa et al. 2010). For randomization, the mature sequence 
of the protease was chosen and the SeSaM template was generated by PCR using 
specially designed primers: SeSaM_FW_BLAP (5’-CACACTACCGCACTCCGTCGC 
TGACGGCCTTCATGCTC-3’) and SeSaM_RV_BLAP (5’-GTGTGATGGCGTGAGGC 
AGCCAACGCACCTTTCAGCAAC-3’). SeSaM library generation was performed as 
previously described (Wong et al. 2008).  
The resulting library was cloned into the pHKL vector using the PLICing method with 
specially designed primers for the amplification of the vector backbone 
PLIC_pHKL_RV (5’-CGCCATTGTCGTTACTTCTGC-3’), PLIC_pHKL_FW (5'-GACT 
TGTCAATGCAGAAGCGGC-3’) and of the mature BLAP sequence PLIC_BLAP_RV 
(5’-CATTGACAAGTCCGCTTCCATACAAGTTC-3’), PLIC_BLAP_FW (5’-CGACAAT 
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GGCGCAATCAGTGC-3’). The phosphorothioated nucleotides are underlined. After 
the vector-backbone amplification, differing from the published method, a subsequent 
gel-extraction was performed to eliminate the PCR template. The iodine cleavage 
and hybridization reactions were performed as previously described (Blanusa et al. 
2010). Subsequently, 20 µL of PLICing reaction were transformed into B. subtilis 
DB104 by protoplast transformation as previously described (Chang and Cohen 
1979). 
3.3.3 Generation of site-saturation and site-directed mutagenesis libraries 
Site-saturation mutagenesis of the BLAP variants at positions 22, 37, 99, 192, 210 
and 218 and site-directed mutagenesis at position 160 and 183 were performed 
according to a standard mutagenesis protocol (Wang and Malcolm 1999). The used 
primers are listed in Table 5. The PCR templates were methylated with dam 
methyltransferase (New England Biolabs) according to the manual, to guarantee 
complete DpnI (New England Biolabs) digestion of the used templates. 
Table 5: Oligonucleotides used for site-directed mutagenesis and generation of SSM libraries. 
Primer/Position Sequence (5' to 3') 
F_E99_SSM GTTTAGGAGCCGACGGTNNKGGTGCAATCAGCTC 
R_E99_SSM GAGCTGATTGCACCMNNACCGTCGGCTCCTAAAC 
F_I192_SSM GCAGGGCTTGACNNKGTCGCACCAGGGGTAAAC 
R_192_SSM GTTTACCCCTGGTGCGACMNNGTCAAGCCCTGC 
F_T22_SSM GCCCATAACCGTGGATTGNNKGGTTCTGGTGTAAAAG 
R_T22_SSM CTTTTACACCAGAACCMNNCAATCCACGGTTATGGGC 
F_T37_SSM CTCGATACAGGTATTTCCNNKCATCCAGACTTAAATATTCGTG 
R_T37_SSM CACGAATATTTAAGTCTGGATGMNNGGAAATACCTGTATCGAG 
F_S210_SSM ACCCAGGTTCAACGTATGCCNNKTTAAACGGTACATCGATGGC 
R_S210_SSM GCCATCGATGTACCGTTTAAMNNGGCATACGTTGAACCTGGGT 
F_S218_SSM CTTAAACGGTACATCGATGGCTNNKCCTCATGTTGCAGGTGCAG 
R_S218_SSM CTGCACCTGCAACATGAGGMNNAGCCATCGATGTACCGTTTAAG 
F_S160G_SDM GTGCAAGCTCAATCGGCTATCCGGCCCG 
R_S160G_SDM CGGGCCGGATAGCCGATTGAGCTTGCAC 
F_F183R_SDM CAACCGCGCCAGCCGTTCACAGTATGGC 
R_F183R_SDM GCCATACTGTGAACGGCTGGCGCGGTTG 
 
3.3.4 Simultaneous saturation mutagenesis of three sites (3xSSM) 
The 3xSSM was performed simultaneously at position 181, 183 and 185. The 
generation was accomplished by using NDT codon degeneracy for position 181 and 
183, involving 12 codons, reducing the number of amino acids to twelve (Arg, Asn, 
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Asp, Cys, Gly, His, Ile, Leu, Phe, Ser, Tyr, Val). These twelve amino acids represent 
a balanced mix of aliphatic, aromatic, polar and non-polar, negatively and positively 
charged amino acids (Reetz et al. 2008). Position 185 was saturated simultaneously 
using NDK codon degeneracy, resulting in 24 codons for 17 amino acids. In addition 
to the NDT combination, five more amino acids (Gln, Glu, Lys, Met, Trp) are included. 
The three degenerated codons were located on the primer 3xSSM_BLAP_PLIC_RV 
(5’-GCCCTGCGCCATAMHNTGAAHNGCTAHNGCGGTTGTTGTTTTGGTCAG-3’), 
which was used in combination with primer FW_BLAP_PLIC to amplify partly the 
mature gene sequence. For the amplification of the vector-backbone and the residual 
mature gene sequence primer 3xSSM_pHKL_PLIC_FW (5’-GGCGCAGGGCTT 
GACATTG-3’) in combination with primer RV_pHKL_PLIC was used. Transformation 
was performed as described in the generation of SeSaM libraries. 
3.3.5 Indicator plates for pre-screening 
Skim milk was used as a substrate for proteolytic activity detection (Sokol et al., 
1979). LB agar plates supplemented with 1 % (w/v) skim milk and 50 µg/mL 
kanamycin were used as pre-screening plates. 
3.3.6 Production of BLAP and variants 
Single colonies of B. subtilis DB104 which showed proteolytic activity in pre-
screening plates were transferred into flat-bottom microtiter plates (pre culture plates) 
containing 200 μl of buffered LB medium (pH 7.6; 1 % (w/v) tryptone, 0.5 % (w/v) 
yeast extract and 1 % (w/v) sodium chloride, 17 mM potassium dihydrogen 
phosphate, 72 mM dipotassium hydrogen phosphate, 50 µg/mL kanamycin) and 
were incubated (37°C, 900 rpm, 18 h, 70 % humidity). The volume of 10 µL pre 
culture was used to inoculate the main culture (150 µL buffered LB, 37°C, 900 rpm, 
24 h, 70 % humidity). After expression, the microtiter plates were centrifuged 
(3,220 g, 20 min, 4°C) to separate the cells from the secreted protease, which was 
obtained in the supernatant. The supernatant was transferred to a new microtiter 
plate for further analysis. 
3.3.7 Screening for increased inhibition by reversible inhibitors 
Screening without supplemented inhibitor was performed by adding 20 µL 
supernatant from each clone to 100 µL of 5 - 50 % Henkel detergent model matrix 
pH 8.6 containing 1.1 mM suc-AAPF-pNA (Bachem). The reaction was carried out in 
flat bottom microtiter plates (Greiner Bio-One GmbH) at room temperature (23°C). 
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The amount of p-nitroanilide released was measured at 410 nm for 5 min using a 
molar absorption coefficient of 8,480/M x cm. One unit is defined as the proteolytic 
activity necessary for the release of 1 µmol of p-nitroanilide per minute. 
The abovementioned setup was used to screen for increased inhibition by 
benzylmalonic acid. The final benzylmalonic acid (Sigma) concentration was 30 mM 
(pH adjustment to 8.6 with NaOH required) corresponding to the necessary 
concentration to reduce the BLAP wild-type activity to ~80 % of its initial activity 
(without supplemented inhibitor). 
For screening in the presence of boric acid, the same described conditions were 
used, where benzylmalonic acid was exchanged by boric acid (Sigma) in a final 
concentration of 14 mM.  
3.3.8 Production and purification of BLAP and variants 
BLAP and its variants were transformed into an industrial Bacillus production strain 
(provided by Henkel AG & Co. KGaA). Expression of BLAP and its variants was 
accomplished by fermentation (1.6 L) using industrial production media in a fed-batch 
process. The purification of BLAP and variants was performed as described in 
chapter 2.4.8 “Production and Purification of BgAP and its variants”. 
Protein concentration of purified BLAP variants was normalized by measuring the 
total protein concentration using the BCA protein assay kit (Thermo Scientific) and 
the homogeneity was analyzed by sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) using a 5 % stacking gel and a 15 % separating gel 
(Laemmli 1970). 
3.3.9 Kinetic characterization of BLAP and variants 
The purified BLAP variants were characterized using the synthetic tetrapeptide suc-
AAPF-pNA (0.13 to 6.03 mM) in 5 % detergent model matrix (pH 8.6, ~50 mS/cm) 
and in Tris/HCl buffer (100 mM, pH 8.6). The proteolytic reaction was initiated by the 
addition of the suc-AAPF-pNA substrate solution (0.13 to 6.03 mM) to the purified 
protease variant (wild-type: 0.30 µM; M1: 8.62 µM; M2: 3.74 µM). The amount of 
p-nitroanilide released was measured at 410 nm for 5 min using a molar absorption 
coefficient of 8,480/M x cm. One unit is defined as the proteolityc activity necessary 
for the release of 1 µmol of p-nitroanilide per minute. The initial velocity data was 
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fitted using GraphPad Prism software (GraphPad software, San Diego, CA, USA; 
hyperbolic fitting). 
3.3.10 Determination of IC50 values of BLAP and variants 
The interaction between BLAP variants and benzylmalonic acid (Sigma) was 
compared by the specific inhibitor concentration required to reduce the protease 
activity to 50 % of the initial value. The proteolytic activity was determined using 
10 µL purified enzyme (wild-type: 0,30 µM; M1: 8,62 µM; M2: 3,74 µM) and 100 µL 
5 % detergent model matrix containing 3.3 mM suc-AAPF-pNA (Bachem) with 
adjusted pH 8.6 (NaOH) and conductivity to ~50 mS/cm (NaCl), which was the final 
conductivity reached by the addition of the maximum benzylmalonic acid 
concentration, with subsequent pH adjustment. Benzylmalonic acid concentration 
varied from 0.5 to 2.9 mM final concentration. Data analysis was performed using 
GraphPad Prism software (GraphPad software, San Diego, CA, USA; symmetrical 
sigmoidal shape fitting). The IC50 value represents the concentration that provokes a 
response half way between the maximal response and the maximally inhibited 
response. 
3.3.11 Computational analysis 
The three-dimensional structures of BLAP parent and its variants were generated 
using the homology model routine from YASARA (Krieger et al. 2002) based on the 
coordinates of the Bacillus lentus alkaline protease (PDB ID: 1ST3; Goddette et al. 
1992). The obtained homology models were energy minimized and equilibrated using 
YASARA (Krieger et al. 2002). Simulations were performed using AMBER03 force 
field (Duan et al. 2003; Krieger et al. 2004). The TIP3P water box (Miyamoto and 
Kollman 1992) was neutralized (pH 8.6, 0.9 % NaCl; Krieger et al. 2006) and the MD 
was performed at 298K and 1 bar using periodic boundary conditions and particle 
mesh Ewald method for long range electrostatics (Essmann et al. 1995) for a 
duration of 2000 picoseconds .  
Docking of benzylmalonic acid in the double deprotonated form to the protease 
variants was performed using AutoDock 4.2 with default docking parameters (Morris 
et al. 1998) and point charges assigned according to the AMBER03 (Duan et al. 
2003) for the protein and GAFF (Wang et al. 2004) force field for the ligand using 
AM1/BCC point charges (Jakalian et al. 2002). The setup was done with the 
YASARA molecular modeling program (Krieger et al. 2002). The docking was 
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performed by fixing the residues in the catalytic triad (Ser215, His62, Asp32) and the 
removal of water molecules from the active site and the S1 binding pocket. The 
simulation cell was defined with 15 Å around the C α-atom of residue Asn153.  
Multiple structural alignments of BLAP and its variants were performed using the 
MUSTANG algorithm (Konagurthu et al. 2006). 
 
3.4 Results 
The results section is divided in six parts: 3.4.1 Development of a detection system 
for altered BLAP inhibition, 3.4.2 Library generation and screening results, 
3.4.3 Investigation of single amino acid substitution in variants V8 and V9, 
3.4.4 Kinetic characterization of BLAP and variants, 3.4.5 Dose response analysis for 
BLAP and its variants tested with benzylmalonic acid and boric acid, and 
3.4.6 Docking analysis. 
3.4.1 Development of a detection system for altered BLAP inhibition 
In order to identify BLAP variants with increased inhibition for benzylmalonic acid 
and/or boric acid, the widely used colorimetric suc-AAPF-pNA assay for proteolytic 
activity detection (Degering et al. 2010; Jaouadi et al. 2010; Stoner et al. 2004), was 
modified. In order to screen for variants with increased inhibition towards reversible 
inhibitors, the inhibitor concentrations necessary to reduce the initial proteolytic 
activity (without supplemented inhibitor) to 80 % was determined. The aim was to see 
a clear difference between the non-inhibited and the inhibited system allowing a 
sufficient range to detect improvements by an increased inhibited variant. An inhibitor 
concentration of 30 mM for benzylmalonic acid and 14 mM for boric acid resulted in a 
determined residual activity of ~80 %. The coefficient of variation is an important 
performance criterion of a screening system to determine its accuracy (Tee and 
Schwaneberg 2006). The developed assay conditions resulted in a true coefficient of 
variation of 6.8 % determined in 50 % detergent model matrix. The matrix 
concentration was varied from 5-50 % without influencing the performance of the 
inhibitor on BLAP and its variants. 
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3.4.2 Library generation and screening results 
The aim of the directed evolution campaign was to generate and identify Bacillus 
lentus alkaline protease (BLAP) variants having increased inhibition towards 
benzylmalonic acid, compared to the BLAP parent. Two consecutive rounds of 
SeSaM (Wong et al. 2008) were performed yielding in the identification of four key 
residues (R1: 181, R2: 183, R3: 185 and R4: 160). Residue 181, 183 and 185 were 
finally saturated simultaneously on the parent S160G, with the subsequent inversion 
of the amino acid substitution to G160S, in order to see cooperative effects. The 
selected variants V8 (S160G, Q185R) and V9 (A181D, F183R) were purified and 
characterized in comparison with the wild-type. Figure 11 shows the genealogic tree 
of the directed BLAP evolution towards increased inhibition by benzylmalonic. 
3.4.2.1 Sequence Saturation Mutagenesis (SeSaM) 
The first round of SeSaM was constructed using BLAP wild-type as the parent, after 
prescreening of ~2000 clones with skim milk indicator plates 1800 proteolytically 
active clones (90 %) were analyzed with the microtiter plate based screening system 
for increased inhibition by benzylmalonic acid and boric acid, developed in this study. 
The identified variants (V1 [I102V]; V2 [A181D]; V3 [F183S]; V4 [Q185R]) were used 
as parents for the second round of diversity generation and showed with position 
181, 183 and 185 already a mutational “hot-spot” (Table 6).  
In the second round of SeSaM, from ~2800 prescreened clones, 1800 remained  
proteolytically active (73 %), which were finally screened for increased inhibition by 
benzylmalonic acid and boric acid in microtiter plates, resulting in four variants with 
altered inhibition behavior (V5 [E99G, I102V, F183S, I192V]; V6 [I102V, F183S]; 
V7 [T22A, T37N, Q185R, S210K, T218A]; V8 [S160G, Q185R]; Table 7). Variants V5 
to V8 carried all at least one amino acid substitution from the first round with up to 
four additional mutations generated in the second SeSaM experiment.  
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Table 6: Summary of the generated and screened variants in SeSaM I and II. 
 
 
SeSaM I SeSaM II 
Parent: BLAP 
 
BLAP 
• V1 [I102V] 
• V2 [A181D] 
• V3 [F183S] 
• V4 [Q185R] 
 
 
Pre-screening: 
 
~2000 variants  
10 % inacive variants  
~2800 variants  
27 % inactive variants  
 
MTP-Screening: 
 
1800 active variants  
50 % detergent matrix 
1800 active variants 
25 % detergent matrix 
Resulting variants: 
 
BLAP 
• V1 [I102V] 
• V2 [A181D] 
• V3 [F183S] 
• V4 [Q185R] 
 
 
BLAP 
• V5 [E99G I102V F183S I192V] 
• V6 [I102V F183S] 
• V7 [T22A T37N Q185R S210K T218A] 
• V8 [S160G Q185R] 
 
 
3.4.2.2 Site-saturation mutagenesis 
The additional amino acid substitutions on variants V5-V7 identified in the second 
round of SeSaM were analyzed using site-saturation mutagenesis (300 clones per 
position) yielding in no further improved variant. Residue 102 was excluded from 
further analysis since the increased inhibition from the single variant turned out to be 
not significant and the improvements of variants V5 and V6, were on a comparable 
level like variant V3 carrying the mutation F183S (Table 7). 
3.4.2.3 Simultaneous saturation of three “hot-spots”  
The identified “hot-spot” positions 181, 183 and 185 were saturated simultaneously 
(3xSSM) with a chosen set of degenerated codons (181: NDT, 183: NDT, 185: NDK) 
on the BLAP parent harboring glycin at position 160, which showed in variant V8 a 
dramatically cooperative effect with the introduced arginine at position 185 (Table 7). 
Further analysis of amino acid 160 exchanged to a set of 9 different amino acids 
resulted in equal benzylmalonic acid inhibition compared to the BLAP parent 
(Table 8).  
In the 3xSSM experiment, 7150 clones were analyzed with the skim milk 
prescreening system and the remaining 1520 proteolytically active colonies (21 %) 
were screened for increased inhibition with the two inhibitors. The screening of the 
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3xSSM essentially resulted in variant V9 [A181D, F183R] having increased inhibition 
for benzylmalonic acid and boric acid (Table 7). 
Variants V8 and V9 were finally selected for detailed characterization due to their 
increase in inhibition with benzylmalonic acid compared to BLAP parent.  
Table 7: Summary of the identified variants after directed BLAP evolution and site-saturation 
mutagenesis analysis towards increased inhibition by benzylmalonic acid. The assay conditions 
resulted in a true coefficient of variation 6.8 %. The reported values are the average of three 
independent measurements. 
Variant 
 Residual activity [%]  
 14 mM 
boric acid 
 
30 mM 
benzylmalonic acid 
 
BLAP (parent)  79 ± 5 % 
 
81 ± 6 % 
V1 [I102V]  71 ± 5 % 
 
79 ± 5 % 
V2 [A181D]  47 ± 3 % 
 
79 ± 5 % 
V3 [F183S]  59 ± 4 % 
 
70 ± 5 % 
V4 [Q185R]  76 ± 5 % 
 
63 ± 4 % 
V5 [E99G I102V F183S I192V]  56 ± 4 % 
 
56 ± 4 % 
V6 [I102V F183S]  57 ± 4 % 
 
70 ± 5 % 
V7 [T22A T37N Q185R S210K T218A]  89 ± 6 % 
 
58 ± 4 % 
V8 [S160G Q185R]  68 ± 5 % 
 
35 ± 2 % 
V9 [A181D F183R]  38 ± 3 % 
 
43 ± 3 % 
V10 [S160G]  71 ± 5 % 
 
80 ± 5 % 
V11 [F183R]  57 ± 4 % 
 
79 ± 5 % 
 
Table 8: Inhibition analysis of position S160. Given values represent the reduction in proteolytic 
activity caused by the supplementation of 30 mM benzylmalonic acid. 
Variant Residual activity [%] 
BLAP (parent) 79 ± 4 % 
S160T 82 ± 6 % 
S160A 75 ± 6 % 
S160G 83 ± 8 % 
S160E 82 ± 7 % 
S160D 83 ± 10 % 
S160I 94 ± 10 % 
S160V 80 ± 3 % 
S160F 80 ± 4 % 
S160Y 81 ± 7 % 
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3.4.3 Investigation of single amino acid substitutions in variants V8 and V9 
The missing variants carrying the single amino acid substitution of variants V8 and 
V9 were generated by site-directed mutagenesis and analyzed with the developed 
microtiter plate screening system (Table 7). In variant 10 the amino acid substitution 
S160G showed no altered inhibition compared to BLAP parent, but amino acid 
substitution Q185R decreased the residual activity caused by 30 mM benzylmalonic 
acid by a difference of 18%. The combination in the final variant 8 showed a 
cooparative effect of the two introduced mutations resulting in a decreased residual 
activity by a difference of 46% compared to BLAP parent. In variants 2 and 11 neither 
amino acid substitution A181D nor F183R showed an effect on the residual activity 
caused by 30 mM benzylmalonic acid. The combination of the two mutations in 
variant 9 causes a synergistic effect and decreased the residual activity by a 
difference of 38% compared to BLAP parent. 
3.4.4 Kinetic characterization of BLAP and variants 
Table 9 summarizes the kinetic data (kcat and Km) of purified BLAP parent and the 
obtained subtilisin variants 8 and 9. 
All generated variants showed in presence and absence of the detergent matrix 
decreased kcat values compared to BLAP parent, for hydrolysis of suc-AAPF-pNA. 
The detergent matrix decreased the kcat values for V8, V9 and BLAP parent around 
4.2, 3.5, and 1.6 times, respectively. The Km value for BLAP parent is consistent in 
presence and absence of the detergent matrix, in contrast to V8 and V9, which 
showed decreased Km values in presence of detergent matrix, meeting those of the 
BLAP parent.   
Table 9: Kinetic parameters of BLAP parent ant its variants determined with varying suc-AAPF-pNA 
concentrations in given buffer systems; normalized to 1 µg (0.037 µmol) of protease. The reported 
values are the average of three measurements. 
  5 % detergent matrix 100 mM Tris/HCl pH 8.6 
  Km [mM] kcat [s
-1
] Km [mM] kcat [s
-1
] 
BLAP (parent) 3.36 ± 0.37 45.55 ± 2.66 3.54 ± 0.37 72.80 ± 4.00 
V8 [S160G Q185R] 3.96 ± 0.46 1.80 ± 0.12 6.20 ± 0.46 7.55 ± 0.36 
V9 [A181D F183R] 2.67 ± 0.42 4.83 ± 0.36 5.88 ± 0.47 16.86 ± 0.84 
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3.4.5 Dose response analysis of BLAP and variants 
Figure 9 shows the dose response curves of the tested variants with benzylmalonic 
acid and boric acid as inhibitor. In Table 10 the corresponding IC50 values are given. 
The IC50 value represents the required inhibitor concentration to reduce the initial 
activity (without inhibitor) to 50 %. 
BLAP parent shows a ~9-times higher affinity towards boric acid (IC50: 25.1 mM) than 
towards benzylmalonic acid (IC50: 221.3 mM). Variant V8 shows with 19.4 mM for 
boric acid an equal IC50 value like its parent but for benzylmalonic acid a significantly 
~9-times lowered IC50 value of 24.1 mM compared to its parent was determined. The 
benzylmalonic acid concentration is equal to the boric acid concentration required to 
reduce the initial parent activity to 50 %. Variant V9 shows a ~3-times lower IC50 
value for boric acid and a ~3-times lowered IC50 value for benzylmalonic acid 
compared to its parent. 
 
Figure 9: Dose-response curves for the BLAP parent, variant 8 [S160G Q185R] and variant 9 [A181D 
F183R] with a) boric acid and b) benzylmalonic acid as inhibitor. 
 
Table 10: The IC50 value represents the required inhibitor concentration to reduce the initial activity 
(without inhibitor) to 50 %. The reported values are the average of three measurements. 
Variant Boric acid [mM]  Benzylmalonic acid [mM] 
BLAP (parent) 25.1 ± 2.7  221.3 ± 36.1 
V8 [S160G Q185R] 19.4 ± 2.3  24.1 ± 2.1 
V9 [A181D F183R] 8.5 ± 1.1  68.5 ± 5.3 
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3.4.6 Docking analysis 
Docking experiments were performed to identify the different possible binding 
conformations between benzylmalonic acid (BMA) and BLAP parent or the generated 
variants. Binding conformations with the lowest calculated docked energies 
belonging to the top-ranked cluster and showing interaction with the introduced 
amino acid substitutions were selected for each protease variant. The main focus of 
the docking analysis was the identification of possible ligand-receptor interactions 
between benzylmalonic acid and the protease molecule, and to suggest how this 
interaction changes with the substituted amino acids, possibly leading to binding 
conformations responsible for the increased inhibition. The docking scoring function 
provided an estimation of the free binding energy, which resulted for the top-ranked 
clusters in values in the range of the standard error of the method (2 kcal/Mol). The 
top-ranked docking poses were used for the identification of new ligand-receptor 
interaction in the variants compared with BLAP. In Figure 10a,b the prominent 
binding modes of benzylmalonic acid and BLAP parent are shown. Additionally 
identified prominent binding modes for benzylmalonic acid and the introduced amino 
acids of variants V8 and V9 are shown in Figure 10c-f. 
In the case of BLAP parent, benzylmalonic acid showed two major orientations 
occupying the catalytic triad or S1 binding pocket (compare Figure 2), both essential 
for the hydrolysis reaction (Figure 10a,b). Benzylmalonic acid shows hydrogen bond 
interactions with Gln 185 and the backbone amine group of Asn 153 (Figure 10a). In 
the second shown orientation benzylmalonic acid blocks the active site by hydrogen 
bond interactions with the catalytic Ser 215 and Asn 153 (Figure 10b).  
In variant V8 [S160G Q185R] the introduced amino acid Arg 185 and the backbone 
amine groups of Asn 153 and Ser 154 (not shown) form hydrogen bonds with the 
inhibitor benzylmalonic acid, which is occupying the S1 binding pocket (Figure 10c). 
In the second encountered binding pose the inhibitor forms hydrogen bonds with Arg 
185 and a surface Arg 164 at the end of the S1 binding pocket (Figure 10d). 
In the docking analysis of variant V9 [A181D F183R], the inserted Arg 182 and the 
Asn 153 form hydrogen bonds with benzylmalonic acid. Benzylmalonic acid is 
blocking residue Asn 153, which is essential for the hydrolysis reaction (Figure 10e). 
In the second novel binding pose the inhibitor builds two hydrogen bonds with 
residue Arg 183 (Figure 10f). Interestingly in both docking conformations a hydrogen 
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bond between the two residues Asp 181 and Arg 183 is formed (Figure 10e,f), which 
could stabilize or support the orientation of Arg 183 in a favored benzylmalonic acid 
binding conformation. 
 
Figure 10: Prominent binding modes of benzylmalonic acid and a,b) BLAP parent c,d) variant V8 
[S160G Q185R] and e,f) variant V9 [A181D F183R]. Orange: catalytic triad (Asp 32, His 63 and Ser 
215). Red: oxyanion hole (Asn 215). Blue and Grey: residues of BLAP parent. Magenta: introduced 
amino acids.  
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3.5 Discussion 
The study described in this chapter aimed to engineer a protease towards increased 
inhibition by benzylmalonic acid. Benzylmalonic acid is an alternative boron-free 
inhibitor with no indications for safety and toxicity risks in liquid detergent 
formulations. Industrial standards are currently boric acid or boric acid derivates 
(Smoum et al. 2012). Currently, the major drawback of benzylmalonic acid is the 
~9-times lower inhibition efficiency compared to boric acid (Table 10). Crystal 
structures of boric acid adducts complexed with a subtilisin were solved and used as 
transition state analogs for serine proteases since the boron atom is tetrahedral and 
the oxygen atom was positioned in the oxyanion hole (Matthews et al. 1975; Menard 
and Storer 1992).  
Conversion of boric acid-protease interactions to benzylmalonic acid-protease 
interactions seemed not plausible since no tetrahedral atom is present in 
benzylmalonic acid and different binding poses are expected to take place. The 
missing knowledge of the specific interaction conformations of benzylmalonic acid 
with the subtilisin protease made directed evolution to the method of choice to alter 
the inhibition efficiency.  
Directed evolution allows tailoring all enzyme properties that can be reflected in a 
screening system (Zhu et al. 2010; Zhu et al. 2006) and lead us to the identification 
of amino acid residues interacting with benzylmalonic acid.  
 
Figure 11: Genealogic tree of directed BLAP evolution towards increased inhibition by benzylmalonic 
acid.  
Interestingly, three (A181, F183 and Q185) out of four (S160, A181, F183 and Q185) 
key residues for inhibition were identified in the first round of SeSaM. It is very 
unusual for directed evolution experiments, to identify three key residues within five 
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amino acids on the sequence, especially as only 2000 variants were sampled in the 
first SeSaM round (Shivange et al. 2009). Recently, a similar finding was reported for 
subtilisin E where four beneficial amino acid residues for GdmCl stability surrounding 
the active site were identified, where SeSaM was used as well as the diversity 
generation method (Li et al. 2012). 
The fourth key residue (S160) was identified in the second round of SeSaM, yielding 
the characterized variant V8 [S160G Q185R]. The subsequent simultaneous 
saturation of three amino acids (A181, F183 and Q185) resulted in variant 9 with the 
beneficial amino acid substitutions A181D and F183R (Figure 11). After purification, 
the kinetic data showed significantly decreased kcat values for the variants V8 and V9 
in buffer and detergent matrix compared to BLAP parent. Further the kcat values 
measured in the detergent matrix are reduced compared to the kcat values 
determined in buffer. A similar behavior of a subtilisin protease from Bacillus lentus in 
heavy-duty liquid detergent formulations was reported (Stoner et al. 2004). However 
the Km values for variants V8 and V9 are in buffer (100 mM Tris/HCl pH 8.6) 
approximately two times increased compared to BLAP parent, but in the matrix the 
Km of the variants decreases to the same level of BLAP parent. The altered specific 
activity for suc-AAPF-pNA variant V8 could result from an altered substrate specificity 
caused by an altered size and charge of the S1 binding pocket resulting from the 
introduced amino acid substitutions S160G and Q185R at the end of the S1 binding 
pocket. The S1 binding pocket is known to play a crucial role for substrate specificity 
in subtilisin proteases (Despotovic et al. 2012; Knight et al. 2007; Pogson et al. 2009; 
Varadarajan et al. 2008). In variant V9, amino acid substitution F183R resulted in a 
more positive charged environment and could directly interact with the oxyanion hole 
(N153) since the distance between Cα N153 and Cα R183 is 4.94 Å. This altered 
oxyanion hole environment is very likely to be the reason for the changed suc-AAPF-
pNA specificity of variant V9 compared to BLAP parent. Amino acids 181, 183 and 
185 are to our best knowledge the first time identified in a directed evolution 
experiment. However, position 160 is well known and described to be a key residue 
in altering substrate specificity for substilisins (Despotovic et al. 2012; Li et al. 2012). 
For detergent applications the kcat values for the artificial substrate suc-AAPF-pNA 
are less important than the kept BLAP parent washing performance tested with 
different egg stains at Henkel AG & Co. KGaA (Data not shown; Henkel AG & Co. 
KGaA internal information). The results of the washing test indicate that the catalytic 
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efficiency determined for the artificial substrate suc-AAPF-pNA of the generated 
variants is not the rate limiting step for washing applications. The major characteristic 
of a detergent protease, like BLAP, is the low substrate specificity to remove 
efficiently protein stains (Maurer 2004), which is represented in the Henkel washing 
tests. 
During the protein engineering campaign we introduced, beside others, two arginine 
residues into variants V8 and V9 leading to the assumption, that the negatively 
charged acid group of benzylmalonic interacts with the positive guanidinium group of 
the arginine. During the docking analysis we observed novel binding poses of 
benzylmalonic acid with the introduced arginines for both characterized variants 
(Figure 10c,d,e,f).  
In variant V8, the key position for inhibitor interaction was 185 since the amino acid 
substitution S160G alone did not result in altered inhibition properties (Table 7). The 
combination of S160G and Q185R further increased inhibition with benzylmalonic 
acid. The introduced arginine at position 185 is more bulky than the replaced 
glutamine. For position 160, the introduced glycine is less bulky than the replaced 
serine, leading to a combinatorial effect in benzylmalonic acid inhibition for amino 
acid substitutions S160G and Q185R. The cooperative effect in terms of inhibition 
could result from the generated space by amino acid substitution S160G, which could 
allow a preferred orientation of the benzylmalonic acid inhibitor next to Arg 185 for a 
stronger interaction (Figure 10c). This novel observed binding poses of 
benzylmalonic acid with variant V8 could be responsible for the ~9-times decreased 
IC50 determined for variant V8 compared to BLAP parent. 
The docking poses observed for variant V9 showed again preferred interactions of 
benzylmalonic acid with the introduced arginine at position 183. Benzylmalonic acid 
binds to R183 and the oxyanion hole residue N153, which is most likely preventing 
hydrolysis. The second inhibitor-ligand complex is not directly interacting with 
catalytically important residues, since benzylmalonic acid interacts in the second 
binding pose exclusively with the introduced arginine at position 183. However, this 
could affect inhibition since it may result in an increased local inhibitor concentration 
close to the catalytic triad and the oxyanion hole. The analysis of single amino acid 
substitution A181D and F183R reveal that both mutations on their own show no 
effect on the inhibition compared to BLAP parent (Table 7) exclusively the 
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combination reduces the IC50 of variant V9 ~3 times compared to BLAP parent. This 
result indicates a crucial role of both mutations (A181D and F183R) in the inhibition 
process. Docking analysis suggested a direct interaction of residue R183 with 
benzylmalonic acid and a novel hydrogen bond interaction of the side chain of the 
introduced aspartate at position 181 with the backbone amine group of R183, which 
may stabilize the orientation of R183 for favored inhibitor interactions (Figure 10e,f). 
Variant V9 showed in addition to the increased inhibition by benzylmalonic acid, an 
~3-times increased inhibition for boric acid compared to BLAP parent. This could 
result from the more positive charge distribution of the surrounding of the oxyanion 
hole (N153) since the distance is 4.94 Å and the negatively charged boric acid is, as 
previously reported, directly interacting with the asparagines residue of the oxyanion 
hole (Matthews et al. 1975). 
In summary, we report for the first time the successful engineering of a subtilisin 
protease towards increased inhibition. Two iterative rounds of directed evolution and 
subsequent simultaneous site-saturation mutagenesis revealed that the identified 
and studied amino acid substitutions in variant V8 [S160G Q185R] as well as V9 
[A181D F185R] are responsible for the improved inhibition by benzylmalonic acid. 
The importance of the introduced arginines was demonstrated in the docking analysis 
since in all novel docking poses of the generated variants with benzylmalonic acid 
(compared to BLAP parent with benzylmalonic) an introduced arginine was directly 
interacting with benzylmalonic acid. The beneficial amino acids for increased 
inhibition are all close to the active-site and the oxyanion hole. This finding is similar 
to the observations made in substrate specificity engineering campaigns where the 
mutated residues are located close to the active site.  
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4 INCREASING PROTEASE PRODUCTION IN BACILLUS SUBTILIS BY DIRECTED 
VECTOR BACKBONE EVOLUTION 
 
4.1 Declaration 
Parts of this chapter were published by the author in the journal AMB Express. 
“Jakob F, Lehmann C, Martinez R, Schwaneberg U (2013) Increasing protein 
production by directed vector backbone evolution. AMB Express 3(1):39” 
 
4.2 Objective 
This project was inspired by the previously described project (chapter 3.2.1), in which 
a high expression level of the secreted protease was required to determine 
proteolytic activity in the detergent matrix. This was accomplished by the use of the 
industrial expression vector pHKL (provided by Henkel AG & Co. KGaA). In this 
project the shuttle-vector pHY300PLK was engineered by directed evolution towards 
increased protease production in B. subtilis DB104, without changing the sequence 
of the expressed enzyme, its promoter-, terminator-, pre- or pro-sequence. 
 
4.3 State of the art 
4.3.1 Advances in heterologous protein production 
Development of cloning and expression technologies to produce heterologous 
proteins in prokaryotic and eukaryotic organisms was a key technology for the rapid 
development of biotechnology in the last three decades, enabling the production of 
numerous enzymes for diagnostic and industrial applications (food, leather, textile or 
detergent industry; Rai and Padh 2001; Kirk et al. 2002). Recombinant production of 
proteins in microbial hosts can be increased by extensive optimization of multiple 
expression factors, such as various temperatures, transcription rates, and media 
composition. In addition, there are several strategies to increase heterologous protein 
expression: protein fusion (Cabrita et al. 2006; Shih et al. 2002; Sorensen and 
Mortensen 2005), codon-optimization of the target gene sequence (Gustafsson et al. 
2004; Li et al. 2003) and metabolic engineering (Heyland et al. 2010; Kabisch et al. 
2012). Protein production levels can be increased by modifying the corresponding 
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promoter, signal and/or secretion sequence (Alper et al. 2005; Xue et al. 1997). 
Caspers et al. and Degering et al. demonstrated the importance of the signal peptide 
for protein secretion in Bacillus subtilis and Bacillus licheniformis. Saturation 
mutagenesis of the N-domain of the α-amylase (AmyE) signal peptide yielded in a 
three-fold increased cutinase activity and protein amounts in the supernatant 
(Caspers et al. 2010). The substitution of a protease signal peptide by a library of 
approximately 400 heterologous signal peptides from B. subtilis and B. licheniformis, 
yielded in the identification of a signal peptide variant leading in a 9-fold increased 
protease secretion (Degering et al. 2010).  
 
Figure 12: Outline of the MEGAWHOP principle: A) mutated DNA fragments (megaprimers) are 
prepared by random mutagenesis. B) megaprimers are annealed to the template plasmid (propagated 
in E. coli dam
+
 strain). C) whole plasmid PCR is carried out. D) The methylated template is DpnI 
digested. E) The nicked circular DNA is transformed into E. coli cells and nicks are repaired in vivo 
(Miyazaki 2011). 
Moreover, expression variants (increased activity due to higher amounts of enzyme, 
but no mutation in the enzyme gene sequence) were identified in the initial rounds of 
directed enzyme evolution campaigns (Tee and Schwaneberg 2007). In this project 
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the random mutagenesis was used to increase protease production levels by 
introducing mutations in the vector backbone of pHY300PLK. The developed strategy 
is based on the MEGAWHOP method (megaprimer PCR of whole plasmid), generally 
used for cloning random gene libraries into a desired expression vector harboring the 
wild type gene (Miyazaki 2003, 2011; Figure 12).  
To increase protein production levels, the mutations were introduced into the vector 
backbone of pHY300PLK by its amplification under error-prone conditions 
(epMEGAWHOP). Subsequently, the generated mutant library was screened for 
increased activity (Sokol et al. 1979; Lawrence et al. 1967; Lehmann et al. 2012; 
Figure 13).  
 
4.4 Material and methods 
All chemicals were of analytical-reagent grade or higher quality and were purchased 
from Carl Roth GmbH (Karlsruhe, Germany), Sigma-Aldrich (Hamburg, Germany) 
and AppliChem (Darmstadt, Germany). Enzymes were purchased from New England 
Biolabs (Beverly, USA) and Fermentas (St. Leon-Rot, Germany). Oligonucleotides 
were purchased from Eurofins MWG Operon (Ebersberg, Germany) in salt-free form. 
Plasmid extraction and PCR purification kits were purchased from Macherey-Nagel 
(Düren, Germany). Microtiter plates (Greiner Bio-One GmbH, Frickenhausen, 
Germany) were incubated in a Multitron II Infors shaker (Infors AG, Bottmingen, 
Switzerland). DNA concentrations were quantified using a NanoDrop photometer 
(Thermo Scientific NanoDrop1000, Braunschweig, Germany). A Mastercycler 
gradient (Eppendorf, Hamburg, Germany) and thin-wall PCR tubes (Multi ultra-tubes; 
0.2 mL; Carl Roth, Germany) were used in all PCRs. 
4.4.1 Bacillus subtilis DB104 and pHY300PLK 
B. subtilis DB104 (Kawamura and Doi 1984) and E. coli DH5α (purchased from 
Agilent Technologies; Santa Clara, USA) were used as hosts for DNA manipulation 
and recombinant protein expression. The shuttle vector pHY300PLK (Takara Bio Inc., 
Shiga, Japan) containing the subtilisin Carlsberg gene was used. 
Chemically competent E. coli DH5α cells were prepared in-house using the rubidium 
chloride technique (Hanahan 1983). Transformation of B. subtilis DB104 was 
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performed using a natural competence based method (Vojcic et al. 2012). 
4.4.2 Gene cloning, construction of pHYscarlsberg, and sequencing 
After double digestion of subtilisin Carlsberg  (Jacobs et al. 1985), including promoter 
and pre-pro-sequence) with BamHI and XmaI, the fragment was subcloned into 
pHY300PLK using T4 DNA ligase. The resulting recombinant plasmid, named 
pHYscarlsberg was transformed into E. coli DH5α and sequenced using 
F_scarlsberg and R_scarlsberg primers (Table 11). DNA sequencing of the identified 
expression vector variants was conducted at Eurofins MWG Operon (Ebersberg, 
Germany) with primers listed in Table 11 and Clone Manager 9 Professional Edition 
(Sci-Ed software, Cary, USA) was used for all sequence alignments.  
 
Table 11: Primers for sequencing analysis of the whole pHYscarlsberg construct. 
Name Sequence (5‘ to 3‘) 
Fw_scarlsberg CAGATTTCGTGATGCTTGTCAGG 
Rev_scarlsberg CGTTAAGGGATCAACTTTGGGAG 
pHY_1 TCCTCATGTAGCGGGAG 
pHY_2 GTATCCCACCAATGTAGCCG 
pHY_3 CCATTACGAGTGCTGGAAATGC 
pHY_4 CGCCTTCTTCTGTGTCATCAAG 
pHY_5 GCCATGTTTCATTGCTCTCCTC 
pHY_6 GGCTTTTAAGCGTCTGTACGTTC 
pHY_7 CGGAGCTGAATGAAGCCATAC 
pHY_8 CGAAGGTTCTCTGAGCTACCAACTC 
 
4.4.3 Generation of error-prone MEGAWHOP libraries 
Megaprimers for the scarlsberg gene were generated by PCR under standard 
conditions. The amplification of the subtilisin Carlsberg gene including promoter-, 
terminator-, pre- and pro-sequence was performed using unmodified DNA primers 
5’-CAGATTTCGTGATGCTTGTCAGG-3’ and 5’-CGTTAAGGGATCAACTTTGGG 
AG-3’ (5 µM each). For the PCR (98°C for 30 sec , one cycle; 98°C, 15 sec/63°C, 
30 sec/68°C, 25 cycles; 68°C for 10 min, one cycle), PfuS DNA polymerase (2.5 U), 
dNTP mix (10 mM), template pHYscarlsberg: 30 ng/µL was used. The PCR product 
(megaprimer) was purified using a PCR purification kit. 
For the epMEGAWHOP PCR (72°C for 5 min, one cycle; 94°C for 1:30 min, one 
cycle; 94°C, 45 sec/60°C, 45 sec/72°C, 5 min, 25 cycles; 72°C for 10 min, one cycle), 
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Taq DNA polymerase (2.5 U), dNTP mix (10 mM) together with plasmid template 
(pHYscarlsberg: 120 ng), megaprimer (scarlsberg: 550 ng) and 0.05 mM Mn2+ were 
used. A subsequent DpnI digestion (20 U) of the template was performed overnight 
at 37°C. The epMEGAWHOP PCR product was transformed into E. coli DH5α and 
the obtained colonies from the agar plates were pooled and used for plasmid 
isolation. Next step was the transformation into the expression host B. subtilis DB104 
using a natural competence based method (Vojcic et al. 2012). 
4.4.4 Indicator plates for prescreening 
For pre-screening, LB agar plates supplemented with 1 % (w/v) skim milk and 
15 µg/mL tetracycline were used for proteolytic activity detection (Sokol et al. 1979). 
4.4.5 Production of subtilisin Carlsberg in microtiter plates 
Single colonies of B. subtilis DB104 from LB skim milk agar plate, that show 
proteolytic activity, were transferred into flat-bottom microtiter plates (preculture 
plates) containing 200 μl of buffered LB medium (pH 7.6; 1 % (w/v) tryptone, 
0.5 % (w/v) yeast extract and 1 % (w/v) sodium chloride, 17 mM potassium 
dihydrogen phosphate, 72 mM dipotassium hydrogen phosphate, 15 µg/mL 
tetracycline) and incubated (37°C, 900 rpm, 18 h, 70 % humidity). The volume of 
10 µL preculture was used to inoculate the main culture (150 µL buffered LB, 37°C, 
900 rpm, 24 h, 70 % humidity). After expression, the microtiter plates were 
centrifuged (3,220 g, 20 min, 4°C) to separate the cells from the secreted protease in 
the supernatant. The supernatant was transferred to a new microtiter plate for 
detailed analysis. 
4.4.6 Colorimetric assay for proteolytic activity of subtilisin Carlsberg 
Proteolytic activity was determined using the synthetic peptide substrate succinyl-L-
Ala-L-Ala-L-Pro-L-Phe-p-nitroanilide (suc-AAPF-pNA) by quantification of the release 
of free p-nitroaniline (pNA) at 410 nm (DelMar et al. 1979). For the screening in 
microtiter plate the proteolytic reaction was initiated by supplementing 10 μl of the 
1:20 diluted supernatant with 1.1 mM suc-AAPFpNA substrate into 100 µL Tris/HCl 
buffer (100 mM, pH 8.6). The release of p-nitroanilide was continuously monitored at 
410 nm in a microtiter plate reader (Tecan Sunrise) and was used for protease 
quantification. 
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4.4.7 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
The protein content from subtilisin Carlsberg supernatants was precipitated with 30 % 
trichloroacetic acid (TCA; 15 min on ice) and resuspended after washing with 
acetone in Tris/HCl (100 mM; pH 8.0). Equal volumes of the concentrated and 
precipitated supernatants were separated by SDS-PAGE (5 % stacking gel and a 
15 % separating gel; Laemmli 1970). 
 
4.5 Results 
The results section is divided in three parts: 4.5.1 Library generation and screening, 
4.5.2 Activity and expression analysis and 4.5.3 Sequencing analysis. 
4.5.1 Library generation and screening  
Figure 13 shows the five steps of the developed epMEGAWHOP protocol. In step I 
the generated DNA fragments (megaprimers) are prepared by PCR and 
subsequently annealed to the template plasmid. Step II comprises the amplification of 
the whole plasmid under error-prone conditions and the methylated template is DpnI 
digested. In step III the nicked circular DNA is transformed into E. coli cells and nicks 
are repaired in vivo. The plasmids are isolated from E. coli and transformed into the 
expression host B. subtilis DB104. The pre-screening on skim milk indicator plates is 
performed in step IV and the colonies showing the biggest diameter of the generated 
halos are transferred into microtiter plates for quantification of the secreted protease 
by activity detection (step V). Vector backbone variants causing increased activity 
were isolated and the wild-type gene sequence of subtilisin Carlsberg was subcloned 
into the mutated backbone as described under Materials and Methods to confirm that 
the improved protein expression can be attributed to the vector backbone 
modification and is not caused by altered enzyme activity. 
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Figure 13: The five key steps for increasing protein production by directed vector backbone evolution. 
Step I: megaprimer generation. Step II: amplification of the vector backbone under error prone 
conditions (epMEGAWHOP). Step III: Transformation of the expression host. Step IV: Agar plate-
based prescreening. Step V: Screening in microtiter plate format to quantify expression levels. 
 
4.5.2 Activity and expression analysis 
The proteolytic activity was determined in the cell free supernatants obtained from 
B. subtilis DB104/pHY-WT-scarlsberg and B. subtilis DB104/pHY-M1-scarlsberg 
containing the secreted protease subtilisin Carlsberg. The supernatant activity of 
pHY-WT-scarlsberg and the identified variant pHY-M1-scarlsberg is shown in Figure 
14a. The obtained supernatant activity of the mutated vector backbone pHY-M1-
scarlsberg shows a ~4-times increased activity compared to the supernatant of the 
initial construct pHY-WT-scarlsberg under the given conditions. In Figure 14b,c a 
SDS-Page of the TCA precipitated cell free supernatants shows a distinct band of 
subtilisin Carlsberg at ~27kDa, except for the empty vector control (no subtilisin 
Carlsberg secreted). The intensity of the corresponding subtilisin Carlsberg band 
obtained from pHY-M1-scarlsberg is compared to its wild-type significantly increased 
(Figure 14b).  
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Figure 14: a) Comparisson of the proteolytic activity of pHYscarlsberg and variant pHY-M1-scarlsberg 
determined in the cell free supernatant; b) Corresponding band of subtilisin Carlsberg in the cell free 
supernatant visualized by SDS-PAGE; c) SDS-PAGE of the cell supernatant for the following 
constructs: EV (DB104/pHY300PLK), WT (DB104/pHYscarlsberg) and M1 (DB104/pHY-M1-
scarlsberg); gray box: corresponding band of subtilisin Carlsberg protease. 
 
4.5.3 Sequencing analysis 
The generated mutant pHY-M1-scarlsberg showed no mutation in the coding gene-
sequences for subtilisin Carlsberg, but the vector backbone (pHY-M1) carried six 
mutations. The allocation of the individual mutations found on the vector backbones 
is shown in Figure 15b. The identified mutation T6007C in the pHY-M1 vector is 
located in a non-coding region of the plasmid. All other 5 mutations could be 
assigned to functional regions. Two mutations are located in the tetracycline 
resistance (TcR) region, encoding a 458 amino acid 50-kDa protein (TET). The 
translation of the TcR sequence into amino acids identified the substitution of 
isoleucine by threonine at position 256 caused by the nucleotide exchange (A to G) 
at position 684. 
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Figure 15: a) Vector map of pHYscarlsberg. The mutations identified for pHY-M1-scarlsberg are 
numbered and marked in green. Nucleotide 1 is regarded as the base after the stop codon (ATT) of 
the mature subtilisin Carlsberg gene. b) Location of the introduced mutations in the vector backbone. 
The positions of the mutations in the corresponding vector backbone are based on the sequenced 
vector backbone prior error-prone amplification. Nucleotide 1 is regarded as the base after the stop 
codon (ATT) of the mature subtilisin Carlsberg gene. (na: no corresponding function of the gene 
sequence could be assigned; pTc
R
/pAp
R
: promoter region Tetracyclin/Ampicilin resistance gen, 
identified with the promoter prediction tool (Reese 2001). 
 
4.6 Discussion 
In white biotechnology, recombinant protein expression is an ongoing challenge. 
Many methods and strategies, such as codon-optimization of the target gene 
sequence (Gustafsson et al. 2004; Li et al. 2003), metabolic engineering (Heyland et 
al. 2010; Kabisch et al. 2012) and/or modifying the corresponding promoter, signal 
and/or secretion sequence (Alper et al. 2005; Xue et al. 1997), are reported to 
increase the level of recombinant produced proteins.  
The MEGAWHOP method is commonly used to insert a mutated target-gene 
sequence into an expression vector. The here developed epMEGAWHOP method 
inverts this strategy and allows the insertion of a not mutated gene into a randomly 
mutated expression vector. This developed strategy is a rapid and straightforward 
way to increase protein expression of any gene for which an activity screening 
system is available.   
Koyanagi et al. reported a method to construct randomly mutagenized plasmid 
libraries free from ligation by using a modified QuikChange site-directed mutagenesis 
protocol. Unspecific mutations were introduced in the gene and the vector-backbone 
during the amplification of the whole vector under error- prone conditions. However, 
the influence of the vector backbone mutations was not analyzed (Koyanagi et al. 
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2008). A similar principle was followed by Matsumura et al. (2005) here the whole 
vector-gene construct was amplified under error-prone conditions with the 
simultaneous introduction of a restriction site, which was afterwards utilized to 
perform an intra-molecular self-ligation step. The possibility that the introduced vector 
backbone mutations could affect the performance of a plasmid was stated, but not 
further discussed since the focus was the improvement of the target enzyme beta-
galactosidase (Matsumura and Rowe 2005). All these protocols had the common 
target to alter the sequence of the expressed target-gene. In the epMEGAWHOP 
approach the aim was to randomly mutagenize the vector backbone of pHY300PLK, 
not the target-gene sequence, to increase the production level of subtilisin Carlsberg 
by Bacillus subtilis DB104. 
The production level of subtilisin Carlsberg was significantly enhanced (up to 4-fold), 
by the random introduction of five mutations and one deletion in the vector backbone 
of pHY300PLK (Figure 14). Sequence analysis confirmed that the subtilisin Carlsberg 
gene, promoter-, terminator-, pre- and pro-sequence was not modified (Figure 15). 
Out of the six introduced mutations, two could be assigned to promoter sequences of 
tetracycline and ampicillin resistance regions. It is reported that mutations in promoter 
regions can cause an altered expression level of the specific gene and/or influence 
the regulatory properties of a given promoter (Alper et al. 2005; Nevoigt et al. 2007). 
Furthermore the mutation A684G resulted in an amino acid exchange in the TET 
protein (Ile256Thr) possibly resulting in an altered repressor behavior beneficial for 
protease secretion. The identified deletion in the origin of replication could increase 
or decrease the copy number of the plasmids in the cells leading to an increased or 
more stable gene expression. Single nucleotide substitutions in the vector pBR322 
are reported to influence the plasmid copy significantly (Boros et al. 1984). However, 
the protein production level is not directly proportional to the plasmid copy numbers, 
but can be affect to a certain extend (Nacken et al. 1996). To determine the distinct 
effect of each mutation, single mutants have to be generated and analyzed in detail 
in case of protease production level, plasmid copy number and/or growth behavior 
with altered tetracycline concentrations.   
The generality of the epMEGAWHOP approach was already demonstrated by 
applying the method to E. coli systems with intracellular Cellulase and periplasmatic 
Lipase production in a group-internal joint project. The observed increase in protease 
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production is not necessarily the limit of the B. subtilis DB104 secretion machinery, 
and therefore the main advantage of epMEGAWHOP is the possibility to optimize the 
vector backbones in iterative rounds. Furthermore, the random mutagenesis of vector 
backbones can be combined with any already existing strategy to further enhance 
protein production in prokaryotes (e.g. signal peptide optimization, fusion protein or 
codon optimization of the target enzyme; Gustafsson et al. 2004; Caspers et al. 2010; 
Cabrita et al. 2006). Especially, the addition of the signal- and promoter- sequence 
for random mutagenesis seems to be a promising and straight forward approach, 
since these regions were already reported for Bacillus sp. having significant effects 
on the production levels of different target enzyme (Caspers et al. 2010; Degering et 
al. 2010). 
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5 SUMMARY AND CONCLUSION 
The goal of this work was to shift the pH activity profile, the thermal resistance of the 
Bacillus gibsonii protease (BgAP) and to increase the inhibition efficiency of the 
Bacillus lentus alkaline protease (BLAP) towards benzylmalonic acid in order to make 
subtilisin proteases BgAP and BLAP applicable for laundry applications. Furthermore, 
a novel method was developed to increase the protease production by vector 
backbone mutagenesis in a directed evolution experiment employing pHY300PLK 
and B. subtilis DB104. 
In the first part we developed a novel rational design strategy to reengineer the 
surface charge of BgAP in order to adapt the pH dependent activity and thermal 
resistance. Out of 113 possible surface amino acids 18 (11 Asn and 7 Gln) residues 
of BgAP were selected and evaluated based on three proposed criteria: (1) The Asn 
or Gln residues should not be conserved, (2) should be surface exposed, and (3) 
neighboured by glycine. Amino acid substitutions of the “deamidation type” (Asn to 
Asp and Gln to Glu) in five out of eight amino acids meeting all criteria resulted in up 
to ~1.5-times increased proteolytic activity. In addition, pH activity profiles of the 
purified variants N253D, Q256E and the combined variant N253DQ256E were 
dramatically shifted towards higher activity at lower pH (range of 8.5-10). Variant 
N253DQ256E showed twice the specific activity of wild type BgAP and its thermal 
resistance was increased by 2.4°C at pH 8.5.  
Surface charge engineering by amino acid substitutions following the “deamidation 
type” is a novel and straightforward sequence alignment based protein engineering 
strategy for modulating pH dependent activity and thermal resistance of subtilisins 
and possibly other enzyme families. It allows the rapid adaptation of pH dependent 
activity for industrial or medical protease applications, such as the adaptation of the 
proteolytic activity to the required pH of detergent formulations (pH powder 
formulations > pH liquid detergent formulations). Compared to the current time 
intensive directed evolution experiments to adapt pH activity or thermal resistance, 
the deamidation strategy is a promising and time-efficient alternative. 
In the second project the interactions of the reversible inhibitor benzylmalonic acid 
with the Bacillus lentus alkaline proteases (BLAP) were investigated; so far protein 
structure-function relationships of benzylmalonic acid and subtilisin proteases have 
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not been explored. Two rounds of directed BLAP evolution towards increased 
inhibition by benzylmalonic acid resulted in variant V8 [S160G Q185R] having a 
~9-times increased inhibition compared to BLAP parent. A subsequently performed 
simultaneous site-saturation mutagenesis at the three identified key residues (A181, 
F183 and Q185) resulted in variant V9 [A181D F183R] showing a ~3-times increased 
inhibition in presence of benzylmalonic acid. Docking analysis of benzylmalonic acid 
with the variants V8, V9 and their parent BLAP, lead to the identification of novel 
inhibitor interactions with the introduced amino acid substitutions. The results provide 
a molecular explanation for the observed increased inhibition of the identified variants 
V8 and V9. The lowered inhibitior concentrations (~9-times) for the generated variant 
V8, enables the replacement of the environmentally problematic inhibitor boric acid 
and derivates by benzylmalonic acid in liquid detergent formulations.  
For the first time a subtilisin protease was engineered towards increased inhibition. 
The boron-free inhibitor benzylmalonic acid combined with the engineered variant V8 
is, to our knowledge, the first known inhibition system capable to replace the 
industrial standard boric acid and derivates from liquid detergent formulations. 
Computational docking analyses provided novel molecular explanations for the 
increased inhibition of BLAP towards benzylmalonic acid. The generated knowledge 
enables the direct transfer of the identified amino acid substitutions to related 
subtilins in order to increase the inhibition towards benzylmalonic acid. This project 
demonstrates the immense potential of directed evolution combined with 
computational analysis to explore and understand novel and/or unknown structure-
function relationships.  
With the random mutagenesis of vector backbones a further promising application of 
directed evolution was developed (epMEGAWHOP). The epMEGAWHOP method 
with subsequent screening for variants with increased protease production offers a 
rapid and straight forward strategy to increase recombinant protein production levels. 
In particular a ~4-times increased production of subtilisin Carlsberg was achieved, 
resulting from a randomly mutated vector backbone library of pHY300PLK. The 
generality of this approach was already shown by applying the epMEGAWHOP 
method to E. coli systems with intracellular and periplasmatic protein production. A 
main advantage is the general application by optimizing expression vectors in 
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iterative rounds of epMEGAWHOP, even when the expression and/or secretion 
pathways of the host organisms are not explored. 
In essence, we developed a novel rational design approach to alter pH dependent 
activity and thermal resistance of the subtilisin BgAP; we reengineered the subtilisin 
BLAP for increased inhibition with benzylmalonic acid matching the performance for 
use in industrial liquid detergent formulations and developed and validated the novel 
epMEGAWHOP method for increased protease production in Bacillus subtilis DB104 
by random mutagenesis of the vector backbone. During the thesis two invention 
reports were filed in a patent application together with Henkel AG & Co. KGaA. 
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